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This thesis mainly describes the development of asymmetric palladium catalysis 
in nucleophilic additions of organoboron reagents to cyclic ketimines to synthesize 
chiral nitrogen-containing compounds with tertiary carbon center. In addition, this 
thesis also depicts the attempts of developing new phosphine based ligands derived 
from amino acids and the preliminary results of their applications in different 
transition-metal-catalyzed asymmetric reactions. 
Chapter 1 gave a brief historical background of asymmetric palladium catalysis. 
The Inventions of three most famous reactions, “TsujiTrost reaction, MizorokiHeck 
reaction and palladium-catalyzed cross-coupling,” were shortly introduced. Beside 
them, the recent progress of palladium asymmetric addition was also summarized and 
a selection of examples in this field were described in details, including 1,4-addition, 
1,2 addition, cycloaddition and so on. 
Chapter 2 demonstrated the high performance of palladium-phosphinooxazoline 
catalyst in asymmetric arylation of cyclic N-sulfonyl ketimines，giving high yields of 
chiral cyclic sulfonamides which bear tetra-substituted stereogenic center. A 
systematic comparison between this catalytic system with others was discussed in the 
main content. 
Chapter 3 further studied the application of palladium-phosphinooxazoline 
catalyst in asymmetric addition of organoboron reagents to cyclic trifluoromethyl 
ketimines. This methodology provided an easy access to anti-HIV drug analogues 
with potential biological activity. 
Chapter 4 presented the development of new phosphine based chiral ligands 
derived from amino acids, including phosphine-amide ligands, phosphine-peptide 
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Chapter 1 Introduction 
 
1.1 Historical background of asymmetric palladium catalysis 
Palladium catalysis is a very important method for constructing carboncarbon 
and carbonheteroatom bonds in organic synthesis and has been widely used in both 
academia and industry for decades. As early as 1959, Wacker process for the 
oxidation of ethylene to acetaldehyde by oxygen in water in the presence of a 
tetra-chloropalladate(II) catalyst was invented (Scheme 1.1).1 It was one of the most 
important milestones in the history of organopalladium chemistry and also the starting 
point of modern palladium chemistry.2 Since then, tremendous efforts have been 
devoted to this area and many new reactions have been developed based on palladium 
catalysis. In recognition of the significance of this research field, the 2010 Nobel 
Prize in Chemistry was awarded jointly to Richard F. Heck, Ei-ichi Negishi and Akira 
Suzuki for their great contribution to palladium-catalyzed cross-coupling reactions. In 
palladium catalysis, palladium-catalyzed asymmetric reactions were undoubtedly very 
appealing and had drawn tremendous attention from synthetic chemists. With the 
development of different chiral ligands as catalyst partners, palladium-catalyzed 
reactions have been shown to be versatile in producing biologically important chiral 
molecules.   
                                                             
1 J. Smidt, W. Hafner, R. Jira, J. Sedlmeier, R. Sieber, R. Ruttinger, and H. Kojer, Angew. Chem. 1959, 71,176.  






Scheme 1.1 The catalytic cycle of Wacker process 
 
Nearly ten years after the invention of Wacker process, Tsuji reported a 
carboncarbon forming substitution reaction which was later known as TsujiTrost 
reaction by using (-allyl)palladium complexes in 1965. 3  Trost et al. further 
advanced this process by developing an asymmetric version later.4 The scope of this 
reaction has been greatly expanded to include many different C, N, or O based 
nucleophiles, and many electrophiles containing different leaving groups, as well as 
many P, N, or S based ligands. In TsujiTrost reaction, palladium catalyst firstly 
coordinates with the allyl group, the oxidative addition subsequently takes place to 
yield chiral -allyl complex 1-2, and attack by the nucleophile  leads to the final 
substitution product 1-3 (Scheme 1.2).  
 
 
Scheme 1.2 The Tsuji-Trost reaction 
                                                             
3 J. Tsuji, H. Takahashi, M. Morikawa, J. Am. Chem. Soc. 1965, 87, 3275. 





Another important carboncarbon bond forming reaction in asymmetric 
palladium catalysis is asymmetric MizorokiHeck reaction (Scheme 1.3a). In the 
early 1970s, Mizoroki5 and Heck6 independently reported a new palladium-mediated 
crossing coupling of alkene with aryl halide. Interestingly, Shibasaki and Overman 
also reported asymmetric examples of MizorokiHeck reaction in 1989.7  They 
achieved intramolecular cyclization by using Pd(OAc)2 as a catalyst and (R)-BINAP 
1-6 or (R, R)-DIOP 1-9 as a chiral ligand (Scheme 1.3b and 1.3c). In this 
transformation,  tertiary and quaternary chiral centers were generated although the 
enantioselectivities were low. Following their seminal work, various new substrates 
and chiral ligands were designed, and now asymmetric MizorokiHeck reaction is 
one of the most efficient methods for preparation of chiral structures containing a 
tertiary and quaternary stereogenic centers. 
                                                             
5 a) T. Mizoroki, K. Mori, A. Ozaki, Bull. Chem. Soc. Jpn. 1971, 44, 581; b) T. Mizoroki, K. Mori, A. Ozaki, Bull. 
Chem. Soc. Jpn. 1973, 46, 1505. 
6 R. F. Heck, J. P. Nolley Jr., J. Org. Chem. 1972, 37, 2320. 
7 a) Y. Sato, M. Sodeoka, M. Shibasaki, J. Org. Chem. 1989, 54, 4738; b) N. E. Carpenter, D. J. Kucera, L. E. 




    Scheme 1.3 Palladium-catalyzed Mizoroki-Heck reaction 
 
Despite palladium-catalyzed cross-coupling reaction arrived quite late in 
palladium catalysis, the impact however was significant. (Scheme 1.4a). Palladium 
overcomes the disadvantages of traditional Mg or Li-mediated cross coupling, such as 
limitation of unhindered alkyl halides as substrates, and the competing side 
reactions.[9d] From 1975 to 1976, several other groups independently reported a 
number of palladium-catalyzed cross-coupling reactions.8 Subsequently that, Negishi 
and co-workers systematically studied this reaction and established the foundation for 
the palladium-catalyzed cross-coupling9 In the 1980s, Hayashi et al. developed 
                                                             
8 a) L. Cassar, J. Organomet. Chem.1975, 93, 253; b) M. Yamamura, I. Moritani, S. I. Murahashi, J. Organomet. 
Chem.1975, 91, C39; c) S. Baba, E. Negishi, J. Am. Chem. Soc. 1976, 98, 6729; d) J. F. Fauvarque, A. Jutand, 
Bull. Soc. Chim. Fr. 1976, 765; d) A. Sekiya, N. Ishikawa, J. Organomet. Chem. 1976, 118, 349. 
9 a) E. Negishi, A. O. King, N. Okukado, J. Org. Chem. 1977, 42, 1821; b) A. O. King, N. Okukado, E. Negishi, J. 
Chem. Soc. Chem. Commun. 1977, 683; c) A. O. King, E. Negishi, F. J. Villani, Jr., A. Silveira, Jr., J. Org. Chem. 
1978, 43, 358; d) N. Okukado, D. E. Van Horn, W. L. Klima, E. Negishi, Tetrahedron Lett. 1978, 1027; e) E. 
Negishi, N. Okukado, A. O. King, D. E. Van Horn, B. I. Spiegel, J. Am. Chem. Soc. 1978, 100, 2254; d) E. 




palladium-catalyzed enantioselective cross-coupling reactions by using phosphorus 
based chiral ligands10 (Scheme 1.4b). 
 
Scheme 1.4 Transition Metal-catalyzed cross-coupling 
 
In addition to the above three most important palladium-catalyzed asymmetric 
reactions, some other important reactions also appeared. One of them is 
palladium-catalyzed asymmetric addition, which is becoming more and more popular, 
and recent progresses in this field will be summarized in section 1.2. 
 
1.2 Palladium-catalyzed asymmetric additions 
Palladium-catalyzed asymmetric addition is a versatile method for 
enantioslective formation of carboncarbon and carbonheteroatom bonds.  
                                                                                                                                                                              
1978, 285–317; f) E. Negishi, Acc. Chem. Res. 1982, 15, 340. 





1.2.1 Asymmetric 1,4-additions 
The first example of conjugated additions of organotin and organomercury 
reagents to -unsaturated ketones by using palladium catalyst in an acidic 
two-phase condition was reported by Cacchi and co-workers.11In 1995, Uemura group 
reported another example of palladium catalyzed 1,4-addition to enones 1-17  in 
which organoboronic acids was first employed as nuclephiles, and higher catalyst 
loading and acidic solvent system were required in that reaction (Scheme 1.5).12 
 
 
Scheme 1.5 The first example of a Pd-catalyzed 1,4-addition of organoboronic acids 
 
However, rhodium catalysis is more favorable than palladium catalysis in the 
1,4-addition, likely due to is the tendency of formed palladium enonate intermeidates 
to undergo -hydride elimination, leading to the heck-type products and palladium(0) 
black rather than hydrolysis (Scheme 1.6).13  
                                                             
11 a) S.Cacchi, D. Misiti, G.Palmieri, Tetrahedron, 1981, 37, 2941; b) S.Cacchi, F. F. Latorre, D. Misiti 
Tetrahedron Lett. 1979, 4591. 
12 C. S. Cho, S. Motofusa, K. Ohe, S. Uemura, J. Org. Chem. 1995, 60, 883. 
13 G. Berthon, T. Hayashi, Rhodium- and Palladium-Catalyzed Asymmetric Conjugate Additions, in Catalytic 





Scheme 1.6 Difference in reactivity between neutral Pd- and Rh- enolates 
 
In 2003, Miyaura and co-workers developed a new catalytic system by using 
[Pd(dppe)(MeCN)2](SbF6)2 as catalyst to dramatically increase the hydrolysis rate and 
obtain the desired additive products in high yields (Scheme 1.7).14 
 
 
Scheme 1.7 Pd/dppe complex catalyzed 1,4-addition of boronic acids 
 
In 2004, Miyaura and co-workers reported the first asymmetric version of 
1,4-addition to-saturated ketones 1-20. In this reaction, the same palladium 
                                                             




catalyst,in combination with (S,S)-dipamp 1-22 and (S,S)-chiraphos 1-23 ligands were 
utilized to introduce asymmetry (Scheme 1.8).15 
 
 
Scheme 1.8 Pd-catalyzed asymmetric 1,4-addition of organoboron reagents to 　　　 
-saturated ketones 
 
Subsequently, the Miyaura group found [Pd (PhCN)2](SbF6)2] and 
(S,S)-chiraphos 1-23 were the best catalyst partners in 1,4-asymmetric additions of 
-saturated ketones 1-24, esters 1-26, amides 1-28 and -aryl enals 1-30 (Scheme 
1.9).16 
 
                                                             
15 T. Nishikata, Y. Yamamoto, N. Miyaura, Chem. Commun. 2004,1822. 
16 a) T. Nishikata, S. Kiyomura, Y. Yamamoto, N. Miyaura, Synlett 2008, 2487; b) T. Nishikata, Y. Yamamoto, N. 





Scheme 1.9 Miyaura’s representative work on Pd-catalyzed asymmtric 1,4-additions 
 
In 2005, another catalytic system combining Pd(OCOCF3)2  and 
(R,R)-Me-duphos 1-38  was reported by Minnaard and co-workers. This catalytic 
system was proven to be most efficient for cyclic -unsaturated ketone and esters 
1-32 (Scheme 1.10).17 
 
                                                             




Scheme 1.10 Pd-catalyzed asymmetric arylations of -unsaturated carbonyl compounds 
 
In 2007, palladacycle was shown to be highly reactive for the addition of 
organoboronic acids to enones by Hu and co-workers.18 In contrast to dicationic Pd 
catalysts, strong Lewis acid AgSbF6 or HBF4 is not necessary for the addition 
reactions, likely due to the extreme stability and robust nature of palladacycle species. 
In 2009, Ohta group disclosed an enantioselective version in which the products were 
obtainedin good yields and promising ee values (Scheme 1.11).19 
                                                             
18 P. He, Y. Lu, C. Dong, Q. Hu, Org. Lett. 2007, 9, 343. 




Scheme 1.11 Palladacycles as catalysts for asymmetric 1,4-addition 
 
The Shi group reported in 2008 that a cationic palladium (II) NHC diaqua 
complex 1-42 is a good catalyst for the asymmetric conjugated addition of arylboronic 
acids to cyclic enones (Scheme 1.12).20 
 
Scheme 1.12 NHC/Pd(II) complex catalyzed asymmetric 1,4-addition 
 
In 2011, the Stoltz group employed a palladium catalyst prepared from 
Pd(OCOCF3)2 and pyridine-oxazoline ligand 1-45 for enantioselective construction of 
                                                             




quaternary stereogenic carbon centers via 1,4-addition of arylboronic acids to 























Scheme 1.13 Pd/pyrox catalyzed 1,4-additions to -substituted cyclic enones 
 
In addition to organoboron reagents, diphenylphposhines are also commonly 
used as nucleophiles in palladium catalyzed asymmetric 1,4-additions. The Song 
group developed a series of Pd pincer-type catalysts 1-49, 1-50, 1-51 and realized an 
efficient 1,4-addition of diphenylphosphines 1-47 to -aryl enones 1-46 (Scheme 
1.14).22 
                                                             
21 K. Kikushima, J. C. Holder, M. Gatti B. M. Stoltz, J. Am.Chem. Soc. 2011, 133, 6902. 




Scheme 1.14 Pd-catalyzed asymmetric addition of Ph2PH to -aryl enone 
 
Recently, Duan and co-workers described highly enantioselctive additions of 
diphenylphisphines to -unsaturated aldehydes 1-52, -unsaturated N-acylpyrrole 
1-54 and -unsaturated ketones 1-56, using a phosphorouscarbonphosphorous 
pincer palladium catalyst 1-58 (Scheme 1.15).23  
                                                             
23 a) Y.-R. Chen, W.-L. Duan, Org. Lett. 2011, 13, 5824; b) J.-J. Feng, X.-F. Chen, M. Shi, W.-L. Duan, J. Am. 




Scheme 1.15 Pd-catalyzed asymmetric additions of diphenylphospine to -unsaturated 
carbonyl compounds 
 
Around the same time, the Leung group reported a chiral palladacycle catalyzed 
enantioselective hydrophosphination of substituted methylidene-malonate esters 1-59 
by applying diphenylphosphine nucleophilic reagents, representing a good method to 
access chiral tertiary phosphines 1-60 (Scheme 1.16).24 Subsequently, the same group 
reported a few other efficient asymmetric addition reactions of diphenylphosphines to 
-unsaturated carbonyl compounds and -unsaturated imines.25 
                                                             
24 C.Xu, G. J. H .Kennard, F. Hennersdorf, Y. Li,S. A. Pullarkat, P.-H. Leung, Organometallics 2012, 31, 3022.  
25 a) Y. Huang, S. A. Pullarkat, Y. Li, P.-H. Leung, Chem.Commun. 2010, 46, 6950; b) Y. Huang, R. J. Chew, Y. Li, 
S. A. Pullarkat, P.-H. Leung, Org. Lett. 2011, 13, 5862; c) Y. Huang, S. A. Pullarkat, S. Teong, R. J. Chew, Y. Li, 
P.-H. Leung, Organometallics 2012, 31, 4871; d) Y. Huang, R. J. Chew, S. A. Pullarkat, Y. Li, P.-H. Leung, J. 




Scheme 1.16 Asymmetric 1,4-addition of HPPh2 reported by Leong et al. 
 
Compared with wide utilization of orgnoboron reagents and diphenylphosphines, 
the reports on other nucleophiles are less common. In a report by Minnaard, 
arylsiloxanes 1-64 was employed to replace arylboronic acids, and good results were 
also obtained (Scheme 1.17).26 
 
 Scheme 1.17 Arylsiloxanes as nucleophiles in Pd-catalyzed 1,4-addition 
                                                             





Amines are also suitable nucleophiles for the above asymmetric 1, 4-additions. 
Hii and co-workers screened 1,4-additions of amines to different -unsaturated 
compounds by using binap-based Pd complex 1-72, and discovered 
alkenoyl-N-oxazolidinones 1-69 were essential for achieving high enantioselectivity 













Pd cat. 1-72(10 mol%)
toluene, rt
18 h *
R1 = Me, Et, n-Pr
R2 = H, Cl, Me, OMe up to 93% yield













Scheme 1.18 Anilines as nuclephiles in Pd-catalyzed asymmetric 1,4-additions 
 
The Sodoka group demonstrated that binap-based Pd complex 1-76 was efficient 
in catalyzing 1,4-additions of anilines to -unsaturated amide 1-73, affording the 
desired products 1-75 in excellent enantioselctivities (Scheme 1.19).28 
                                                             
27 K. Li, P. H. Phua, K. K. Hii, Tetrahedron 2005, 61, 6237. 




Scheme 1.19 Pd-catalyzed enantioselective protonation via 1,4-addition 
 
In 2001, the Mikami group reported asymmetric Friedel-Crafts alkylations of 
indole 1-77 and pyrrole 1-80 with -unsaturated ketoesters 1-78 by employing 
chiral dicationic Pd complexes 1-83 (Scheme 1.20).29 
 
Scheme 1.20 Pd-catalyzed enantioselective Friedel-Crafts alkylation 
                                                             





1.2.2 Asymmetric 1,2-additions 
Asymmetric 1,2-additions of different nucleophiles to imines, aldehydes and 
ketones are powerful methods to synthesize chiral amines, secondary and tertiary 
alcohols, and many transition-metals such as Rh, Cu and Pd can be used as a catalyst 
for these reactions. Compared with Rh and Cu, Pd catalyzed 1,2-addition was less 
developed owing to the competitive reductive elimination and -hydride elimination 
of palladium species during the reaction.   
 
1.2.2.1 Imine substrates  
Imines are important and practically useful substrates in organic synthesis. The 
difficulties associated with additions to imines are their poor electrophilicity and the 
tendency of enolizable imines to undergo deprotonation. Back to just a few years ago, 
only few examples on palladium-catalyzed 1,2-addition to imines were reported.30 
In 2008, the Sodeoka group disclosed a highly enantioselective catalytic 
Mannich-type reaction of -ketoesters with N-Boc imines, using Pd2+ diaqua complex 
1-90 (Scheme 1.21).31  
                                                             
30 a) H. Nakamura, K. Nakamura, Y. Yamamoto, J. Am. Chem. Soc.1998, 120, 4242; b) M. Shimizu, M. Kimura, T. 
Watanabe, Y. Tamaru, Org. Lett. 2005, 7, 637; (c) N. Solin, O. Wallner, K. Szabó, Org. Lett. 2005, 7, 689 




Scheme 1.21 Sodeoka’s work on Pd-catalyzed asymmetric addition of -ketoesters to imines 
 
In 2007, a cationic palladium-complex 1-93-catalyzed was employed by Lu and 
co-workers to catalyze the addition of arylboronic acids to N-tert-butanesulfinyl 
iminoacetates 1-91, and optically active arylglycine derivatives 1-92 with moderate to 
good yield and high diastereoselectivity were obtained. (Scheme 1.22a).32 This 
example represents the first arylation of imines via palladium catalysis. Shortly after 
this report, the same group utilized pymox 1-96 as chiral ligand to achieve an 
asymmetric addition of arylboronic acids to N-tosylimine 1-94 to yield 
diarylmethylamines 1-95 . A number of other ligands based on biphenyl 1-98, 
binaphthyl 1-99 and bis(oxazoline) 1-97 scaffolds were also screened, however, only 
pymox 1-96 led to moderate yield and good enantioselectivity (Scheme 1.22b).33 
                                                             
32 H. Dai, X. Lu, Org. Lett. 2007, 9, 3077 




Scheme 1.22 Asymmetric arylations of imines by Lu et al. 
 
In 2009, the Shi group disclosed 1,2-additions of arylboronic acids and indoles 
1-104 to N-tosylimine, employing NHC based Pd2+ catalysts 1-102 and 1-106, 
affording the desired products in  moderate yields and good enatioselectivities 
(Scheme 1.23a and 1.23b).34 One year later, the same group reported the asymmetric 
addition of cyclic -keto esters to N-Boc imines catalyzed by a cationic Pd(II) NHC 
complex 1-109 (Scheme 1.23c).35 
 
                                                             
34 a) G.-N. Ma, T. Zhang, M. Shi, Org. Lett. 2009, 4, 875; b) Z. Liu, M. Shi, Tetrahedron: Asymmetry 2009, 20, 
119. 
35 a) R. Zhang, D. Wang, Q. Xu, J. Jiang, M. Shi, Chin. J. Chem. 2012, 30, 1295; b) R. Zhang, Q. Xu, L.-Y. Mei, 




Scheme 1.23 Shi’s work on Pd-catalyzed asymmetric additions to Ts- and Boc- imines 
 
In 2012, Zeng and co-workers developed a method for Pd(II)-catalyzed 
asymmetric arylation of N-aryl imino esters 1-110, in which Pd(II)-bisoxzazoline 
complex 1-112 was proved to be efficient (Scheme 1.24a).36 In the same year, the 
Lam group used another novel Pd(II)-bisoxzazoline complex 1-116 for catalytic 
enantioselective addition of alkylazaarenes 1-113 to N-Boc imines (Scheme 1.24b).37 
                                                             
36 J. Chen, X. Lu, W. Lou, Y. Ye, H. Jiang, W. Zeng, J. Org. Chem. 2012, 77, 8541 




Scheme 1.24 Bisoxazolines as ligands in Pd-catalyzed asymmetric additions to imines 
 
The Shibata group used novel Pd pincer-type catalyst 1-121a in the asymmetric 
reactions of benzyl nitriles 1-117 and N-tosylimines (Scheme 1.25a).38 Subsequently, 
the same group described asymmetric aza-MBH reactions of acrylonitriles 1-119 with 
















Pd cat.1-121a (5 mol%)
AgOAc (5 mol%)
K2CO3 (1.0 eq.)










Pd cat.1-121b (5 mol%)
AgOAc (5 mol%)
DABCO (1.0 eq.)
















Scheme 1.25 Pd-catalyzed enantioselective additions of nitriles to N-tosylimines 
                                                             
38 K. Hyodo, S. Nakamura, K. Tuji, T. Ogawa, Y. Funahashi, N. Shibata, Adv. Synth. Catal .2011, 353, 3385. 





Recently, Zhou and co-workers reported a palladium-catalyzed allylation of 
imines, using allylic alcohols 1-122 as allylic reagents. The newly developed spiro 
monodentated phosphoramidite based palladium complex 1-124 showed high 
catalytic activity. (Scheme 1.26).40 
Scheme 1.26 Pd-catalyzed asymmetric allylation of imines 
 
Compared with branched imines, cyclic imines were less investigated in the 
palladium catalytic asymmetric 1, 2-addition reactions. In one of the early reports in 
2006, the Sodeoka group employed Pd catalyst 1-132 to promote addition of 
manolate 1-130 cyclic imines DHIQs 1-128, affording the desired additive productz 
1-131 in high yields and good to excellent enantioselectivities (Scheme 1.27).41  
 
                                                             
40 X.-C. Qiao, S.-F. Zhu,W.-Q. Chen, Q.-L. Zhou, Tetrahedron: Asymmetry 2010, 21, 1216. 




Scheme 1.27 Pd-catalyzed 1,2-addition of malonates to cyclic imines 
 
Very recently, the Zhang group reported a palladium/pyrox 1-135-catalyzed 
addition of arylboronic acids to ketimines 1-133, the products 1-134 were obtained in 
up to 99% yield and 96% ee. The reactions could be run under aerobic conditions and 
with trifluoroethanol as the solvent (Scheme 1.28).42  
 
Scheme 1.28 Pd-catalyzed enantioselective arylation of boronic acids to cyclic ketimines 
 
1.2.2.2 Aldehydes and ketones as the substrates 
Besides imines, aldehydes and ketones are also widely used substrates in 
1,2-addition reactions.  
In 2009, Qin and co-workers reported an asymmetric addition of arylboronic 
acids to N-benzylisatins 1-136 catalyzed by Pd(OAc)2 and phosphine-schiff base type 
                                                             




ligand 1-138, giving the 3-aryl-3-hydroxyoxindoles 1-137 in moderate yields and ee 
values. A strong Lewis acid BF3Et3O was crucial for this transformation (Scheme 
1.29).43  
 
Scheme 1.29 Qin’s work on the asymmetric addition of boronic acids to isatins 
 
In 2011, the Shi group examined the same reaction by using their (NHC) Pd2+ 
diaqua complex 1-102 as the catalyst,  both reactivities and enantioselctivities were 
improved to excellent levels (Scheme 1.30).44 
 
 
Scheme 1.30 Shi’s work on the asymmetric addition of boronic acids to isatins 
 
The Mikami group developed a SEGPHOS-Pd complex 1-144 catalytic system 
                                                             
43 H. Lai, Z. H. Huang, Q. Wu, Y. Qin, J. Org. Chem. 2009, 74, 283. 




and applied it in the asymmetric ketoester-ene reaction, providing optically active 
-hydroxy silyl enol ether 1-143 in good yields and high ee values (Scheme 1.31a).45 
Subsequently, the same group reported dicationic Pd complex 1-147 catalyzed 
enantioselective ene and aldol reactions with isatin derivatives (Scheme 1.31b).46 In 
2010,  they also disclosed that dicationic (S)-BINAP-Pd complex 1-151 was efficient 
in catalyzing asymmetric addition of alkynylsilanes 1-148 to trifluoropyruvate 1-149 
(Scheme 1.31c).47 
 
Scheme 1.31 Pd-catalyzed enatioselective ene and aldol reactions 
 
Chiral Pd(II)-BINAP complex 1-90 was also used by the Sodeoka group for 
enantioslective aldol reaction of -keto esters with formaldehyde, and the 
                                                             
45 K. Mikami, Y. Kawakami, K. Akiyama, K. Aikawa, J. Am. Chem. Soc. 2007, 129, 12950. 
46 K. Aikawa, S. Mimura, Y. Numata,  K. Mikami, Eur. J. Org. Chem. 2011, 62. 




desiredadducts  1-153 were obtained with moderate to good yields and with good ee 
values (Scheme 1.32).48 
 
 
Scheme 1.32 Pd-catalyzed asymmetric hydroxymethylation of -keto ester 
 
 In 2009, the Shi group examined a series of (NHC) Pd2+ complexes 1-157 in the 
enantioselective allylation of aldehydes 1-155 with cyclohexenyl acetate 1-154 in the 
precence of Et2Zn as additive, producing homoallylic alcohols 1-156 in moderate to 
high yields, with modest ee values, and up to 99:1 syn to anti. A good number of 
phosphine-schiff base type ligands 1-158 were also screened in the same reaction and 
proved to be inferior to NHC based ligands (scheme 1.33).49 
 
                                                             
48 I. Fukuchi, Y. Hamashima, M. Sodeoka, Adv. Synth. Catal. 2007, 349, 509. 
49 a) W. Wang, T. Zhang, M. Shi, Organometallics 2009, 28, 2640; b) J.-J. Jiang, D. Wang, W.-F. Wang, Z.-L. 




Scheme 1.33 Comparison between NHC based ligands and P-imine ligands in Pd-catalyzed 
asymmetric allyations of aldehydes. 
 
Although the asymmetric addition of arylboronic acids to arylaldehydes have been 
wildly reported, the application of chiral Pd catalysts has not been very successful. In 
2010, the Shi groupreported asymmetric arylation of arylaldehydes with arylboronic 
acid by using (NHC) Pd2+ complex 1-109 as catalyst, giving the adducts with 
promising results (Scheme 1.34).50 
 
 
                                                             




Scheme 1.34 Pd-catalyzed enantioselective arylation of aldehydes with arylboronic acids 
 
1.2.2.3 Olefin substrates  
 
In 2006, the Morken group developed a one-pot synthesis of β-amidoketones 
1-161 from allenes 1-159, using tartaric acid based phosphorus ligand 1-162 and 
Pd2(dba)3 catalyst. In this reaction, the chiral Pd catalyst was proved to be very 
efficient, giving rise to the formation of key intermediates 1-160 in optically active 
forms (Scheme 1.35).51 
 
Scheme 1.35 Pd-catalyzed asymmetric addition of B2(pin)2 to allenes 
 
From 2007 to 2012, Sigman and co-workers developed a catalytic system 
comprising Pd(MeCN)2Cl2 and (S)-iPr-Quinox 1-169, and showed its effectiveness in 
enantioslective difunctionalizations of alkenes involving the addition of two distinct 
                                                             




nucleophiles(Scheme 1.36).52  
 
Scheme 1.36 Enantioselective Pd-catalyzed difunctionalizations of alkenes 
 
A combination of (S)-Siphos-PE 1-174 and Pd2(dba)3 was used by the Wolfe 
group in 2010 to catalyzed asymmetric alkene carboamination reactions of 
N-boc-pent-4-enylamines 1-170 with alkenyl or aryl bromide, and the products 1-171 
were obtained in good to excellent yields and with moderate to good 
enantioselectivities (Scheme 1.37a).53 Subsequently, the same group further applied 
the same catalytic system to enantioselective carboamination reaction of urea 
                                                             
52 a) Y. Zhang, M. S. Sigman, J. Am. Chem. Soc. 2007, 129, 3076; b) K. H. Jensen, T. P. Pathak, Y. Zhang and M. 
S. Sigman,J. Am. Chem. Soc. 2009, 131, 17074; (c) R. Jana, T. P. Pathak, K. H. Jensen, M. S. Sigman, Org. Lett. 
2012, 14, 4074. 




derivatives 1-172 to produce chiral cyclic compounds 1-173 in good yields and 
moderate ee values (Scheme 1.37b).54  
 
Scheme 1.37 Pd-catalyzed intramolecular cyclization via asymmetric additions to olefins 
 
In 2011, Trost and co-workers reported an asymmetric Pd-catalyzed 
hydrocarbonation of allenes between benzyloxyallene 1-176 and oxindole 1-175 with 
the employment of the Trost ligand 1-178, forming the desired products 1-177 bearing 
a quaternary stereocenter in excellent chemo-, regio-, diastereo- and 
                                                             




enantioselectivities (Scheme 1.38).55 
 Scheme 1.38 Pd-catalyzed asymmetric hydrocarbonation of allenes 
 
The Shi group developed the asymmetric addition of arylboronic acids to 
cumulene derivatives 1-179 catalyzed by chiral cationic Pd2+ diaqua complex 1-109 in 
2011, affording allenic esters 1-180 in good to excellent yields and moderate to good 
enantioselectivities (Scheme 1.39).56 
 
 
Scheme 1.39 Pd-catalytic asymmetric addition of arylboronic acids to cumulenes 
  
1.2.3 Asymmetric cycloadditions  
In 2007, the Lu group reported a palladium-catalyzed asymmetric intramolecular 
addition of vinyl-palladium species to ketones under mild conditions, producing the 
corresponding cycloaddition products 1-182 in high yields and high 
                                                             
55 B. M. Trost, J. Xie, J. D. Sieber, J. Am. Chem. Soc. 2011, 133, 20611. 




enantioselectivities. Among all the screened bisphosphine ligands, (S,S)-BDPP 1-183 
was identified as the best catalyst (Scheme 1.40a).57 In the same year, the Lu group 
also developed an enantioselective tandem [3+2] annulation of 2-acylarylboronic 
acids 1-184 with substituted alkynes 1-185, affording chiral 1-indenols 1-186 in high 
yields and excellent enantioselectivities. This time, Pd(OTf)2·2H2O/1-187 system was 
found to be the best (Scheme 1.40b).58 
 
Scheme 1.40 Lu’s work on Pd-catalyzed asymmetric cycloadditions 
 
In 2008, a Pd-catalyzed enantioselective arylative cyclization of allenyl 
aldehydes 1-188 with arylboronic acids was demonstrated by the Tsukamoto group, 
and cis-fused five- and six-membered cyclic homoallylic alcohols 1-189 were 
obtained. A series of bisphosphine ligands were screened and only BINAP based 
                                                             
57 J. Song, Q. Shen, F. Xu, X. Lu, Org. Lett. 2007, 9, 2947.  




ligands 1-190 showed good catalytic acitivities (Scheme 1.41).59 
Scheme 1.41 Pd-catalyzed asymmetric arylative cyclization of allenyl aldehyde 
 
Very recently, the Mikami group reported a highly enantioselective [2+2] 
cycloaddition of alkynes 1-191 with trifluoropyruvate 1-149 by using a chiral 
dicationic BINAP/Pd catalyst 1-151, affording oxetene derivatives 1-192 in good to 
excellent yields and high ee values (Scheme 1.42).60  
 
 
Scheme 1.42 Pd-catalyzed enantioselective [2+2] cycloaddition 
 
The Yang group reported a palladium(II)-catalyzed enantioselective oxidative 
cascade cyclization of olefinic substrates 1-193, using Pd(MeCN)2Cl2/AgOTf as 
catalyst. Only Quinox type ligands 1-169 were shown to be effective in this study 
                                                             
59 H. Tsukamoto, T. Matsumoto, Y. Kondo, Org. Lett. 2008, 10, 1047 









Pd(MeCN)2Cl2 (10 mol%)L* 1-169 (10 mol%)
AgOTf (20 mol%), MS 3A







1-169a R = Bn, 80% yield, 76% ee
1-169b R = iPr, 66% yield, 72% ee
1-169c R = tBu, 62% yield, 93% ee





Scheme 1.43 Pd-catalytic enantioselective oxidative cascade cyclization 
 
In 2010, the Trost group employed phosphoramidite ligands 1-198 ina 
palladium(II)-catalyzed asymmmetric [3+2] cyclization between trimethylenemethane 
1-195 and imines 1-196, generating highly optically active substituted pyrrolidines 
1-197 (Scheme 1.44).62 
 
Scheme 1.44 Pd-catalyzed asymmmetric [3+2] cyclization 
                                                             
61 W. He, K.-T. Yip, N.-Y. Zhu, D. Yang, Org. Lett. 2009, 11, 5626. 





1.2.4 Asymmetric 1,6-additions 
Although asymmetric 1,6-addition have been successfully achieved by rhodium, 
iridium, copper as well as organic catalysis, the reports of palladium-catalyzed 
asymmetric 1,6-addition are very rare. Very recently, Duan and co-workers developed 
a palladium-catalyzed asymmetric 1,6-addition of diarylphosphines to 
electron-deficient dienes 1-199, furnishing the optically active allylic phosphine 
derivatives 1-200 in good yields with high enantioselectivities (Scheme 1.45).63 
 
Scheme 1.45 Duan’s work on Pd-catalyzed asymmetric 1,6-addition 
 
1.3 Project objectives 
Asymmetric palladium catalysis is a well established method for enantioselective 
synthesis of chiral molelcules. Since the initial report, many palladium catalyzed 
asymmetric reactions have been developed over the decades, including asymmetric 
allylic alkylations, asymmetric Heck reactions, asymmetric cross-couplings, and 
asymmetric additions, among others. Pd-catalyzed asymmetric additions of various 
nucleophiles to C=X bonds (X= C, N, O) are becoming more and more important, due 
                                                             




to their high efficiency, flexible substrate scopes and mild reaction conditions. 
However, Pd-catalyzed asymmetric additions lagged well behind the reactions 
mediated by other transition metals such as rhodium, iridium and copper. Owing to 
the tendency of palladium species to undergo competitive reductive elimination and 
-H elimination , palladium catalyzed asymmetric additions are much less developed 
d.[13] We therefore decided to focus on this potentially promising research area and 
intended to develop some new catalytic reactions. Specifically, we would like to 
tackle asymmetric additions of organoboron reagents to imines by palladium catalysis 
as good examples are rare. During the progress of our research, Zhang and co-workers 
reported a palladium-catalyzed asymmetric addition to cyclic imines. However, the 
scope of their reaction was unfortunately narrow, only five-membered imines could be 
used, and the reaction was not applicable to six-membered ring cyclic imine 
substrates. .[42] 
Another objective of our research concerns with the development of chiral 
ligands. Chiral ligands are extremely important in transition metal catalysis, and 
majority of known ligands are not easily prepared. In this context, chiral ligands that 
can be readily derived from natural chiral building blocks are certainly very appealing. 
Many new kinds of chiral ligands are synthesized based on rational design and 
applied in metal catalyzed reactions every year. Actually, great progress has been 
achieved in this field and some of the developed chiral ligands which are called 
“privileged ligands,”64 are proved to have good enaotioslectivity and high efficency 
                                                             
64 a) T. P. Yoon, E. N. Jacobsen, Science 2003, 299, 1691; b) A. Pfaltz, W. J. Drury III, Proc. Natl. Acad. Sci. USA 




over a wild range of different reactions. Recently, our group developed a new class of 
mono-phosphine catalysts showing excellent reactivity and enantioselectivity in many 
organocatalytic asymmetric reactions.65 These catalysts were all readily derived from 
natural amino acids, and their utilization as chiral ligands in transition metal catalysis 
is unknown. Another objective of this thesis is to design and synthesize amino 
acid-based chiral phosphine ligands, and employ them in the palladium catalyzed 
asymmetric reactions.  
In chapter 2, the high performance of palladium-phosphinooxazoline catalyst in 
asymmetric arylation of cyclic N-sulfonyl ketimines will be described in detail. In 
chapter 3, the application of palladium-phosphinooxazoline catalyst in asymmetric 
addition of organoboron reagents to cyclic trifuoromethyl ketimines to synthesize 
anti-HIV drug analogues will be disclosed. In chapter 4, our efforts to prepare various 
types of amino acid-based phosphine-schiff base ligands and their applications to 
asymmetric reactions will be described. 
 
                                                             
65 a)X. Han, Y. Wang, F. Zhong, Y. Lu, J. Am. Chem. Soc. 2011, 133, 1726; b) F. Zhong, X. Han, Y. Wang, Y. Lu, 
Angew. Chem. Int. Ed. 2011, 50, 7837; c) F. Zhong, X. Han, Y. Wang, Y. Lu, Chem. Sci. 2012, 3, 1231; d) X Han, 





Chapter 2 High Performance of a Palladium 
Phosphinooxazoline Catalyst in Asymmetric 
Arylation of Cyclic N-Sulfonyl Ketimines 
 
2.1 Introduction 
Rhodium- or palladium-catalyzed asymmetric addition of arylboron reagents to 
imines is one of the most efficient methods of producing chiral disubstituted and 
tri-substituted methylamines.66 Among the imines used for the asymmetric arylation, 
cyclic N-sulfonyl imines have recently attracted considerable attention owing to their 
advantages over others in that they have generally higher reactivity towards the 
catalytic arylation and their cyclic structure makes enantioface differentiation of imine 
easier and simpler because of no syn-anti equilibration.  
In 2012, Hayashi and co-workers reported the first example of asymmetric 
addition of arylbroxines 2-2 to cyclic N-sulfonyl ketimines 2-1 in the presence of a 
rhodium catalyst coordinated with a chiral diene ligand 2-4, affording benzosultams 
2-3 in excellent yields and enantioselectivity (Scheme 2.1).67 
                                                             
66 For reviews on the transition metal-catalyzed asymmetric addition of organometallic reagents to imines, see: a) 
S. Kobayashi, Y. Mori, J. S. Fossey, M. M. Salter, Chem. Rev. 2011, 111, 2626; b) C. S. Marques, A. J. Burke, 
ChemCatChem 2011, 3, 635; c) K. Yamada, K. Tomioka, Chem. Rev. 2008, 108, 2874; d) G. K. Friestad, A. K. 
Mathies, Tetrahedron 2007, 63, 2541. For recent examples of the transition metal-catalyzed asymmetric addition 
of organometallic reagents to imines, see: a) S. Hirner, A. Kolb, J. Westmeier, S. Gebhardt, S. Middel, K. Harms, 
P. von Zezschwitz, Org. Lett. 2014, 16, 3162; b) Z. Cui, Y.-J. Chen, W.-Y. Gao, C.-G. Feng, G.-Q. Lin, Org. Lett. 
2014, 16, 1016; c) B. Gopula, C.-W. Chiang, W.-Z. Lee, T.-S. Kuo, P.-Y. Wu, J. P. Henschke, H.-L. Wu, Org. 
Lett. 2014, 16, 632. 
67 a) T. Nishimura, A. Noishiki, G. C. Tsui, T. Hayashi, J. Am. Chem. Soc. 2012, 134, 5056. See, also: b) T. 
Nishimura, A. Noishiki, Y. Ebe, T. Hayashi, Angew. Chem. Int. Ed. 2013, 52, 1777; c) T. Nishimura, A. Y. Ebe, 




Scheme 2.1 Hayashi’s work on Rh-catalyzed asymmetric addition to N-sulfonyl ketimines 
 
Shortly after that, Lam group disclosed an Rh-catalyzed enantioselective addition 
of alkenylboron reagents 2-6 to cyclic imines 2-5 employing a rhodium complex 
based on chiral diene ligands 2-12 (Scheme 2.2a).68 They also applied the same 
catalytic system in the enantioselective nucleophilic allylations of cyclic imines using 
potassium allyltrifluoroborates 2-10 as nucleophiles and proceeded high 
enanotioselectivity and distereoselctivity (Scheme 2.2b).69 
 
                                                             
68 a) Y. Luo, A. J. Carnell, H. W. Lam, Angew. Chem. Int. Ed. 2012, 51, 6762 





 Scheme 2.2 Lam’s work on Rh-catalyzed asymmetric addition to N-sulfonyl cyclic imines 
 
Xu group in 2013 developed a new, simple sulfonamide-based olefin ligand 2-17 
and used it in the asymmetric Rh-catalyzed arylations of cyclic ketimines, achieving 
high enantioselectivitve products with stereogenic quaternary carbon center (Scheme 
2.3).70 
 
Scheme 2.3 Xu’s Sulfur-olefin ligand in asymmetric addition to N-sulfonyl cyclic imines 
                                                             






In addition to rhodium catalysis, Zhang and co-workers reported a 
palladium-catalyzed asymmetric addition of organoboronic acids to cyclic imines. 
This catalytic system showed high efficiency and excellent enantioselectivity under 
aerobic conditions and with unpurified solvent (scheme 2.4).71 
 
Scheme 2.4 Zhang’s work on Pd-catalyzed arylation of cyclic imines 
 
A summary of the catalytic asymmetric arylation of cyclic N-sulfonyl imines 
reported to date with rhodium (Hayashi, Lam, Xu) and palladium (Zhang) complexes 
as catalysts is illustrated in Scheme 2.5.   
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Scheme 2.5 Reactivity and utility of cyclic N-sulfonyl imines 
 
The cyclic N-sulfonyl imines used as the arylation substrates are classified into 
aldimines and ketimines, where the former is more reactive than the latter in general 
and some of the ketimines substituted with electron-withdrawing groups such as ester 
and CF3 are as reactive as aldimines. The basic structure of the cyclic N-sulfonyl 
imines so far used is either 5-membered ring imine leading to benzosultam or 
6-membered one 1 leading to benzosulfamidate. Although the 5-membered ring 
imines have high reactivity giving the corresponding sultams upon arylation even for 




purity is not trivial67a. On the other hand, the 6-membered ring imines are less reactive 
towards the arylation while the resulting sulfamidates are known to undergo ring 
opening without loss of heir enantiomeric purity.72 As a result there have been very 
few reports on the catalytic asymmetric addition to the 6-membered ring ketimines 1 
(R = alkyl, aryl) in high yields. 
 
2.2 Results and discussions 
During our studies on the catalytic asymmetric addition of organoboron reagents 
to carbon–carbon and carbon–hetero atom double bonds,73 it was found that a 
cationic palladium complex coordinated with a chiral phosphine-oxazoline ligand 
showed high catalytic activity and high enantioselectivity in the asymmetric addition 
of arylboronic acids to cyclic N-sulfonyl ketimines (R = alkyl, aryl) to give high 
yields of chiral cyclic sulfonamides which bear tetra-substituted stereogenic center.74 
 
2.2.1 Catalytic system comparison 
The results obtained for the addition of phenylboronic acid (2m) to N-sulfonyl 
aldimine 2-18a (R = H) and ketimine 2-18b (R = Me) in the presence of a cationic 
                                                             
72 Ring opening of benzosulfamidate with nickel-catalyzed Grignard cross-coupling, see: a) P. M. When, J. Du 
Bois, Org. Lett. 2005, 7, 4685. Ring opening with LiAlH4 reduction, see: b) Y.-Q. Wang, C.-B. Yu, D.-W. Wang, X.-B. Wang, Y.-G. Zhou, Org. Lett. 2008, 10, 2071.   
73 For reviews on the rhodium-catalyzed asymmetric addition of arylboron reagents, see: a) T. Hayashi, K. 
Yamasaki, Chem. Rev. 2003, 103, 2829; b) S. Darses, J.-P. Genet, Eur. J. Org. Chem. 2003, 4313; c) J. 
Christoffers, G. Koripelly, A. Rosiak, M. Rössle, Synthesis 2007, 1279; d) N. Miyaura, Bull. Chem. Soc. Jpn. 
2008, 81, 1535; e) J. D. Hargrave, J. C. Allen, C. G. Frost, Chem. Asian J. 2010, 5, 386; f) H. J. Edwards, J. D. 
Hargrave, S. D. Penrose, C. G. Frost, Chem. Soc. Rev. 2010, 39, 2093; g) P. Tian, H.-Q. Dong, G.-Q. Lin, ACS 
Catal. 2012, 2, 95. For a review on the palladium-catalyzed asymmetric addition of arylboron reagents, see: 
Y.-W. Sun, P.-L. Zhu, Q. Xu, M. Shi, RSC Advances 2013, 3, 3153.   
74 A chiral phosphinooxazoline–palladium complex has been used as a catalyst for the asymmetric addition of 
arylboronic acids to isatins:  Q. Li, P. Wan, S. Wang, Y. Zhuang, L. Lia, Y. Zhou, Y. He, R. Cao, L. Qiu, Z. 




palladium complex coordinated with (S)-i-Pr-phox75 are summarized in Table 2.1, 
which also contains, for comparison, those for the reaction in the presence of other 
palladium and rhodium complexes so far reported as effective catalysts for the 
asymmetric arylation of N-sulfonyl imines. The best result was obtained with the 
catalyst generated in situ from PdCl2((S)-i-Pr-phox)76 and AgBF4 in dichloroethane. 
Thus, aldimine 2-18a was allowed to react with 2-19m (2 eq to 2-18a) in the presence 
of 5 mol% of the cationic palladium catalyst in dichloroethane at 65–70 °C for 12 h to 
give a quantitative yield of the phenylation product 2-20am, which is an R isomer of 
99.6% ee (entry 1).  The same reaction conditions were successfully applied to the 
reaction of ketimine 2-18b, which gave the corresponding phenylation product 
(R)-2-20bm[6] of 99.5% ee in a quantitative yield (entry 1).  The generation of 
cationic palladium species is essential for the high catalytic activity. In the absence of 
AgBF4, no phenylation was observed for either aldimine 2-18a or ketimine 2-18b 
(entry 2). AgOTf is not a choice of the silver salt which gave only a low yield (10%) 
of 3am and no 2-20bm (entry 3). A palladium complex generated from Pd(OCOCF3)2 
and (S)-i-Pr-phox catalyzed the phenylation of aldimine 2-18a efficiently in 
CF3CH2OH at 80 °C, but its catalytic activity was lower for ketimine 1b giving a 
modest yield (58%) of (R)-2-20bm although the enantioselectivity was high (99.8% 
ee) (entry 4). Cationic palladium bisphosphine complexes77 generated by mixing 
                                                             
75 a) P. von Matt, A. Pfaltz, Angew. Chem., Int. Ed. Engl. 1993, 32, 566; b) J. Sprinz, G. Helmchen, Tetrahedron 
Lett. 1993, 34, 1769; c) G. J. Dawson, C. G. Frost, J. M. J. Williams, S. J. Coote, Tetrahedron Lett. 1993, 34, 
3149. 
76 a) Y. Uozumi, K. Kato, T. Hayashi, Tetrahedron: Asymmetry 1998, 9, 1065; b) A. J. Blacker, M. L. Clarke, M. S. 
Loft, M. F. Mahon, M. E. Humphries, J. M. J. Williams, Chem. Eur. J. 2000, 6, 353. 
77 Cationic bisphosphine-palladium catalysts have been used for conjugate addition to α,β-unsaturated carbonyl 
compounds: For reviews: a) A. Gutnov, Eur. J. Org. Chem. 2008, 4547; b) Y. Yamamoto, T. Nishikata, N. 




PdCl2[(S,S)-chiraphos] and PdCl2[(S)-binap] with AgBF4 were not so catalytically 
active as that with the phosphine-oxazoline, (S)-iPr-phox, as a ligand. They catalyzed 
the phenylation of aldimine 2-18a to some extent, but they were not catalytically 
active for ketimine 2-18b (entries 5 and 6). Palladium complexes coordinated with 
chiral oxazoline-pyridine ligands, (S)-iPr-pyrox and its derivatives, have been 
reported by Zhang to be catalytically active for the addition to 5-membered-ring 
ketimines. In our hands, his palladium catalyst system, Pd(OCOCF3)2 and 
(S)-i-Pr-pyrox in CF3CH2OH, did not catalyze the phenylation of ketimine 2-18b 
well,78 while it is highly active for the phenylation of aldimine 2-18a (entry 7).  A 
cationic palladium complex generated by the addition of AgBF4 to 
PdCl2[(S)-i-Pr-pyrox] also catalyzed the addition to aldimine 2-18a very efficiently, 
but it is not active for ketimine 2-18b in either CF3CH2OH or dichloroethane (entries 
8 and 9). Chiral diene/rhodium catalysts, which we previously reported to be most 
active for the asymmetric arylation of ketimines including the 5-membered-ring ones, 
catalyzed the phenylation of aldimine 2-18a to give 2-20am of high % ee in a 
quantitative yield (entries 10 and 11). They also catalyzed the asymmetric phenylation 
of ketimine 1b with high enantioselectivity, but the yields of 3bm are not so high as 
those observed with the present cationic palladium/(S)-iPr-phox catalyst. The binap–
rhodium catalyst was less active than the diene-rhodium as reported 
                                                                                                                                                                              
Completely Revised Edition (Ed.: D. G. Hall), Wiley-VCH: Weinheim, 2011; Vol. 1, Chap. 5, pp 263–313. 
78 Zhang reported (ref 6) that the addition of PhB(OH)2 to 1b (R = Me) catalyzed by a chiral pyridyloxazoline-palladium complex in a sealed tube charged with oxygen at 80 °C for 48 h gave 58% yield of 
the corresponding benzosulfamidate (95% ee); A palladium complex coordinated with chiral pyridinooxazoline 
ligand was reported to be an efficient catalyst for asymmetric conjugate addition to cyclic enones: a) K. 
Kikushima, J. C. Holder, M. Gatti, B. M. Stoltz, J. Am. Chem. Soc. 2011, 133, 6902; b) J. C. Holder, A. N. 





Table 2.1 Catalytic Asymmetric Addition of Phenylboronic Acid (2-19m) to Cyclic 
N-Sulfonyl Aldimine 2-18a and Ketimine 2-18b [a] 
 
 Catalyst (5 mol%) 
additives 
Solvent 










(99.6% ee, R) 
99% 
(99.5% ee, R) 






































































(98.0% ee, R) 
76% 
(97.0% ee, R) 
11 [RhCl((R)-diene*)]2 




(99.6% ee, R) 
30% 
(99.3% ee, R) 
12 [RhCl((S)-binap)]2 




(89% ee, S) 
< 3% 
(-) 
[a] Reaction conditions: 2-18a (0.10 mmol), 2-19m (0.20 mmol), catalyst (5 mol%), additive, solvent 
(1.0 mL) at a given temperature for 12 h. [b] Isolated yield of 2-20am or 2-20bm. [c] Determined by 
HPLC analysis with chiral columns. The absolute configurations of 2-20am and 2-20bm were 





2.2.2 Reaction monitoring  
By monitoring the reaction progress of the palladium-catalyzed addition to 
ketimine 2-18b for comparison of the Pd/phox catalyst with Pd/pyrox catalyst (entries 
1 vs 7), it was revealed that the low yield with the Pd/pyrox catalyst is due mainly to a 
short life of the catalyst system. Thus, the reaction with Pd/pyrox catalyst gave 7% 
yield the product 2-20bm within 10 min, but the yield was not increased after 10 min.  
In contrast, the Pd/phox catalyst was found to keep its high catalytic activity for at 
least one hour to give high yield of 2-20bm (Table 2.2 and 2.3).   
 
Table 2.2 Details of monitoring the reaction process of 2-18a[a] 
 
 




10 83% 78% 
20 88% 79% 
30 93% 83% 
60 98% 90% 
120 99% 98% 
240 99% 99% 
[a] Reaction conditions: 2-18a (0.10 mmol), 2-19m (0.20 mmol), catalyst (5 mol%), additive, solvent 
(1.0 mL). [b] Isolated yield of 2-20am. 
Table 2.3 Details of monitoring the reaction process of 2-18b[a] 
 
t [min] Yield[b] of condition A Yield[b] of condition B Yield[b] of condition C
10 88 0 6 
20 94 0 7 
30 97 0 7 
60 99 0 7 
120 99 0 7 
240 99 0 7 
[a] Reaction conditions: 2-18b (0.10 mmol), 2-19m (0.20 mmol), catalyst (5 mol%), additive, solvent 





2.2.3 Substrate scope 
The cationic palladium catalyst generated from PdCl2[(S)-i-Pr-phox] and AgBF4 
was found to have wide applicability in the asymmetric addition of arylboronic acids 
to the methyl-substituted ketimine 2-18b (Table 2.4). The addition of phenylboronic 
acids substituted at para position with methyl, phenyl, phenoxy, and halides all gave 
the corresponding arylation products with high enantioselectivity (>98% ee) in high 
yields (entries 3, 5–8). For those arylboronic acids which are not reactive enough to 
give high yields of the arylation products under the standard condition (condition A), 
the use of AgSbF6 and K3PO4 as additives (condition B) improved the chemical yields 
with keeping the high enantioselectivity. The effects of the additives are summarized 
in entries 12–15 and details are shown in Table 2.5 for the addition of 
2-MeOC6H4B(OH)2 (2-19w) to ketimine 2-18b. The reaction under the condition A 
(AgBF4) gave only a modest yield (56%) of the arylation product 2-20bw, though the 
enantioselectivity is high (99.5% ee).  With AgSbF6 (condition C) the yield was 
improved to 90%, but the product was racemic. This is probably due to an acid 
contaminated in AgSbF6 which causes racemization of the product by way of a 
benzylic cation intermediate. Addition of K3PO4 as a week base together with AgSbF6 
inhibited the racemization to give a high yield of 2-20bw with high % ee.  
Combination of K3PO4 and AgBF4 did not improve the yield of the product. Under 
the condition B, meta- and ortho-substituted phenylboronic acids gave the arylation 




enantioselectivity were also observed in the addition to cyclic ketimines 2-18c and 
2-18d, which are ethyl and pentyl imines, respectively (entries 19–21).  
 
Table 2.4 Palladium-Catalyzed Asymmetric Addition of Arylboronic Acids 2-19m−z to 
Cyclic N-Sulfonyl Ketimines 2-18b−d.[a] 
 
 2-18,conditions[b] ArB(OH)2 2-19 2-20, yield [%][c] ee [%][d]
1 2-18b, A 
2-19m 
2-20bm, 99 99.5 (R)
2 2-18b, B 2-20bm, 99 99.6 (R)
3 2-18b, A 
2-19n 
2-20bn, 99 98.1 (R)
4 2-18b, A 
2-19o 
2-20bo, 99 98.8 (R)
5 2-18b, B 
2-19p 
2-20bp, 99 99.9 (R)
6 2-18b, A 
2-19q 
2-20bq, 99 98.6 (R)
7 2-18b, A 
2-19r 
2-20br, 87 98.4 (R)
8 2-18b, A 
2-19s 




9 2-18b, A 
2-19t 
2-20bt, 95 99.9 (R)
10 2-18b, B 
2-19u 
2-20bu, 51 99.4 (R)
11 2-18b, A 
2-19v 
2-20bv, 99 99.4 (R)
12 2-18b, A 
2-19w 
2-20bw, 56 99.5 (R)
13 2-18b, B 2-20bw, 88 99.9 (R)
14 2-18b, C
[e] 2-20bw, 90 0 
15 2-18b, D
[e] 2-20bw, 48 99.7 (R)
16 2-18b, B 
2-19x 
2-20bx, 95 99.7 (R)
17 2-18b, B 
2-19y 
2-20by, 98 99.9 (R)
18 2-18b, B 
2-19z 
2-20bz, 51 99.9 (R)
19 2-18c, B 
2-19m 
2-20cm, 99 99.5 (R)
20 2-18c, A 
2-19n 
2-20cn, 99 99.5 (R)
21 2-18d, A 
2-19m 
2-20dm, 99 99.4 (R)
[a] Reaction conditions: 1 (0.10 mmol), 2 (0.20 mmol), PdCl2[(S)-i-Pr-phox] (5 mol%), additive, 
dichloroethane (1.0 mL) at 65–70 °C for 12 h. [b] A: AgBF4 (15 mol%). B: AgSbF6 (15 mol%) and 




absolute configurations are proposed to be R by similarity of the stereochemical pathway to that giving 
(R)-3bm. [e] C: AgSbF6 (15 mol%). D: AgBF4 (15 mol%) and K3PO4 (15 mol%). 
 
Table 2.5 Condition screening for asymmetric addition of 2-19w to 2-18b[a]  
 
 
 Conditions  2-20bw, yield[b] [%] ee[c] 
[%] 
1 15% AgBF4, ClCH2CH2Cl 56 99.9 
2 10% AgSbF6(pre-formed), ClCH2CH2Cl 80 55 
3 10% AgBF4(pre-formed), ClCH2CH2Cl 0 - 




5 15% AgSbF6, 1eq. K2HPO4, ClCH2CH2Cl
~20 - 
6 15% AgBF4, EtOH 0 - 
7 15% AgBF4, Dioxane 0 - 
8 15% AgBF4, TFE 66 n. d. 
9 15% AgBF4, toluene 23 n.d. 




11 5% AgSbF6, ClCH2CH2Cl 0 - 
[a] Reaction conditions: 2-18b (0.10 mmol), 2-19w (0.20 mmol), catalyst (5 mol%), additive, solvent 
(1.0 mL). [b] Isolated yield of 2-20bw. [c]Determined by HPLC analysis with chiral columns. 
 
The asymmetric addition to cyclic ketimines with aryl groups on the imine 
carbon are more challenging because they are less reactive than those with alkyl 
groups, and the arylation products, triarylmethylamines, are more likely to undergo 
racemization under the reaction conditions (Table 2.6). The reaction of ketimine 2-18e 
with 4-methoxyphenylboronic acid (2-19p) in the presence of PdCl2((S)-i-Pr-phox) 
(10 mol%) and AgSbF6 (30 mol%) proceeded well to give the corresponding arylation 
product 2-20ep in 75% yield, but it was racemic (entry 1). The formation of racemic 
product was also observed in the presence of inorganic base K3PO4 (30 mol%), which 
corresponds to condition B in Table 2, or K2CO3 (entries 2 and 3).79 Finally, it was 
found that the addition of proton sponge prevents the product from racemization 
under the reaction conditions (entry 5).  In the presence of proton sponge, several 
triarylmethylamine products were obtained with high enantioselectivity (entries 6–8). 
 
Table 2.6 Palladium-Catalyzed Asymmetric Addition of Arylboronic Acids to Cyclic 
N-Sulfonyl Aryl Ketimines 2-18e−g.[a] 
                                                             
79 The racemization of arylation product 3ep under the reaction conditions was confirmed experimentally by 
exposing enantiomerically enriched 3ep (99.2% ee) to the reaction conditions of entry 3 in Table 2.6, which 






 2-18, additive Ar2B(OH)2 2-19 2-20, yield [%][b] ee [%][c]
1 2-18e, - 
2-19p 
2-20ep, 75 0 
2 2-18e, K3PO4 2-20ep, 73 0 
3 2-18e, K2CO3 2-20ep, 70 0 
4 2-18e, NEt3 2-20ep, 63 81 
5 2-18e, proton sponge 2-20ep, 80 99.2 
6 2-18f, proton sponge 
2-19p 
2-20fp, 65 99.6 
7 2-18g, proton sponge 
2-19p 
2-20gp, 75 96 
8 
2-18g, proton sponge 
2-19n 
2-20gn, 68 97 
[a] Reaction conditions: 1 (0.10 mmol), 2 (0.20 mmol), PdCl2[(S)-i-Pr-phox] (10 mol%), AgSbF6 (30 
mol%), additive (30 mol%), dichloroethane (1.0 mL) at 65–70 °C for 12 h. [b] Isolated yield. [c] 






Treatment of the asymmetric arylation products 2-20cn and 2-20gn with LiAlH4 
gave the corresponding 2-hydroxyphenylmethylamines 2-21cn and 2-21gn, 
respectively, without loss of their enantiomeric purities (Scheme 2.6).[7b] 
 
 
Scheme 2.6 Ring-opening of the asymmetric arylation products 2-20 
 
2.3 Conclusions 
To summarize, a cationic palladium complex coordinated with chiral 
phosphine-oxazoline ligand (iPr-phox) showed high catalytic activity and 
enantioselectivity in the asymmetric addition of arylboronic acids to 6-membered 
cyclic N-sulfonyl ketimines to give high yields of chiral cyclic sulfamidates with 96–
99.9% ee which bear tetra-substituted stereogenic center.   
 
2.4 Experimental section 
 
2.4.1. General Information 
All the starting materials were obtained from commercial sources and used 




from sodium benzophenone ketyl prior to use. DME and CH2Cl2 were distilled from 
CaH2 prior to use. 1H and 13C NMR spectra were recorded on a Bruker AMX500 
(500 MHz) spectrometer. Chemical shifts were reported in parts per million (ppm), 
and the residual solvent peak was used as an internal reference: proton (chloroform δ 
7.26), carbon (chloroform δ 77.0). Multiplicity was indicated as follows: s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), and br s 
(broad singlet). Coupling constants were reported in Hertz (Hz). Low resolution 
mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI mode, and 
a Agilent Tech. 5975C inert MSD. All high resolution mass spectra were obtained on 
a Finnigan/MAT 95XL-T spectrometer. For thin layer chromatography (TLC), 
Merck pre-coated TLC plates (Merck 60 F254) were used, and compounds were 
visualized with a UV light at 254 nm. Further visualization was achieved by staining 
with iodine, or ceric ammonium molybdate followed by heating on a hot plate. Flash 
chromatographic separations were performed on Merck 60 (0.040-0.063 mm) mesh 
silica gel. The Enantiomerically excesses of products were determined by 
chiral-phase HPLC analysis, using a Daicel Chiralpak IC column (250 x 4.6 mm), 
Chiralpak AD-H column (250 x 4.6 mm), or Chiralcel OD-H column (250 x 4.6 
mm). 
All the aryboronic acids are commercially available and used as received. The 
palladium complex PdCl2[(S)-iPr-phox][76a] was prepared from PdCl2(MeCN)2 and 




All the cyclic N-sulfonyl ketimines 2-18a-g were prepared according to the 






The preparation of cyclic ketimine 2-18b: Anhydrous formic acid (20.0 mmol, 921 
mg, 0.75 mL) was added dropwise to neat chlorosulfonyl isocyanate (20.0 mmol, 2.83 
g, 1.74 mL) at 0 °C with rapid stirring. Vigorous gas evolution was observed during 
the addition process. The resulting viscous suspension was stirred at room 
temperature until gas evolution ceased (1-2 h). To the resulting sulfamoyl chloride 
(ClSO2NH2) was added 2’-hydroxyacetophenone (10.0 mmol). After the mixture was 
cooled under ice-cooling, 15 mL of DMA (N,N-dimethyl-acetamide) was slowly 
added. Caution: a mild exotherm was noted upon combining these reagents. After the 
ice-cooling was removed, the mixture was stirred for 10 min, and sodium hydride 
(480 mg of 60% dispersion in mineral oil, 12.0 mmol) was added in portions. After 
stirring at rt for 30 min, another sodium hydride (480 mg of 60% dispersion in 
mineral oil, 12.0 mmol) was added in portions again. After stirring for 1 hour at rt the 
reaction mixture was allowed to stir overnight (8-12 h) at 50 °C. The reaction was 
quenched by the addition of H2O and the aqueous layer was extracted with EtOAc. 
The combined organic layers were washed with brine, and concentrated under 
reduced pressure. The residue was purified by chromatography on silica gel 
(hexane/ethyl acetate = 3/1) to give compound 2-18b as a colorless solid (1.13 g, 57% 
yield). 
The ketimines, 2-18d, 2-18e, and 2-18g, are new compounds. Their analytical data are 





Compound 2-18d. 53% yield; A colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.81 (dd, J = 
8.0, 1.5 Hz, 1H), 7.70 (td, J = 7.5, 1.6 Hz, 1H), 7.68 (td, J = 7.6, 1.6 Hz, 1H), 7.30 (dd, J = 8.3, 
0.9 Hz, 1H), 2.02 (t, J = 7.5 Hz, 2H), 1.83 (quintet, J = 7.5 Hz, 2H), 1.47–1.33 (m, 4H), 0.93 
(t, J = 7.2 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 180.3, 152.6, 136.8, 127.9, 125.8, 119.3, 




Compound 2-18e. 45% yield; A colorless solid. 1H NMR (500 MHz, CDCl3) δ 7.74 
(td, J = 7.5, 1.6 Hz, 1H), 7.68 (d, J = 8.2 Hz, 2H), 7.67 (dd, J = 7.9, 1.6 Hz, 1H), 7.40 
(d, J = 8.4 Hz, 1H), 7.37 (d, J = 8.0 Hz, 2H), 7.37 (td, J = 7.3, 1.1 Hz, 1H), 2.49 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 176.2, 154.6, 144.4, 136.7, 131.8, 130.9, 130.8, 







Compound 2-18g. 37% yield; A colorless solid. 1H NMR (500 MHz, CDCl3) δ 7.75 
(td, J = 7.9, 1.5 Hz, 1H), 7.66 (dd, J = 7.9, 1.4 Hz, 1H), 7.61 (s, 1H), 7.53 (d, J = 7.5 
Hz, 1H), 7.49 (d, J = 7.6 Hz, 1H), 7.45 (d, J = 7.5 Hz, 1H), 7.41 (t, J = 6.8 Hz, 1H), 
7.38 (td, J = 7.4, 1.0 Hz, 1H), 2.46 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 176.5, 
154.6, 139.0, 136.8, 134.0, 132.7, 131.8, 130.9, 128.6, 127.9, 125.6, 119.4, 116.7, 
21.4. HRMS (EI) m/z calcd for C14H11NO3S 272.0460, found 272.0458. 
 
2.4.3 Palladium-Catalyzed Asymmetric Arylation of Ketimines 
As representative experimental procedures, those for entries 1 and 2 in Table 2.4 and 
entry 5 in Table 2.6, are shown below.   
 
Entry 2 in Table 2.4: PdCl2[(S)-iPr-phox] (2.9 mg, 0.0050 mmol), ketimine 2-18b 
(19.7 mg, 0.100 mmol), and benzeneboronic acid (2-19m) (24.4 mg, 0.200 mmol) 
were placed in Schlenk tube under nitrogen. To the tube, 1,2-dichloroethane (0.5 mL) 
was added, and then AgBF4 (2.9 mg, 0.015 mmol) in 1,2-dichloroethane (0.5 mL) was 




directly subjected to flash chromatography on silica gel using hexane/ethyl acetate 
(4:1) as an eluent to give 2-20bm as a colorless solid (27.2 mg, 99% yield). 
Entry 2 in Table 2.4: PdCl2[(S)-iPr-phox] (2.9 mg, 0.005 mmol), ketimine 2-18b 
(19.7 mg, 0.100 mmol), benzeneboronic acid (2-19m) (24.4 mg, 0.200 mmol), and 
K3PO4 (2.2 mg, 0.015 mmol) were placed in Schlenk tube under nitrogen. To the tube, 
1,2-dichloroethane (0.5 mL) was added, and then AgSbF6 (5.2 mg, 0.015 mmol) in 
1,2-dichloroethane (0.5 mL) was added dropwise to the resulting mixture over 1 min. 
The reaction mixture was stirred at 65–70 °C for 12 h, and it was directly subjected to 
flash chromatography on silica gel using hexane/ethyl acetate (4:1) as an eluent to 
give 2-20bm as a colorless solid (27.3 mg, 99% yield). 
 
Entry 5 in Table 2.6: PdCl2[(S)-iPr-phox] (5.8 mg, 0.010 mmol), ketimine 2-18e 
(27.3 mg, 0.100 mmol), 4-methoxyphenylboronic acid (2-19p) (60.8 mg, 0.400 
mmol), and proton sponge (6.4 mg, 0.030 mmol) were placed in Schlenk tube under 
nitrogen. To the tube, 1,2-dichloroethane (0.5 mL) was added, and then AgSbF6 (10.3 
mg, 0.030 mmol) in 1,2-dichloroethane (0.5 mL) was added dropwise to the resulting 
mixture over 1 min. The reaction mixture was stirred at 65–70 °C for 12 h, and it was 
directly subjected to flash chromatography on silica gel using hexane/ethyl acetate 







Compound 2-20am. A colorless solid. []25D +17 (c 0.51, CHCl3). [Ref.[72b]: 98% ee, 
[α]25D 24.2 (c 0.60, CHCl3), S configuration]. 1H NMR (500 MHz, CDCl3) δ 7.49–
7.41 (m, 3H), 7.38–7.30 (m, 3H), 7.10 (td, J = 7.6, 1.0 Hz, 1H), 7.08 (d, J = 8.2 Hz, 
1H), 6.83 (d, J = 7.7 Hz, 1H), 5.91 (d, J = 8.7 Hz, 1H), 4.72 (d, J = 8.5 Hz, 1H). 13C 
NMR (125 MHz, CDCl3) δ 151.5, 137.8, 129.7, 129.6, 129.5, 128.8, 128.6, 125.2, 
122.0, 118.8, 62.0. The ee value was 99.6%, tR (major) = 16.6 min, tR (minor) = 20.2 
min (Chiralpak IC, λ = 220 nm, hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). 







Enantiomerically enriched 2-20am 
 
 
Compound 2-20bm. A colorless solid. []25D +18 (c 0.46, CHCl3). [Ref.[66]: 95% ee, 
[α]25D +12.7 (c 0.18, CHCl3), R configuration]. 1H NMR (500 MHz, CDCl3) δ 7.40–
7.32 (m, 6H), 7.18 (td, J = 7.7, 1.2 Hz, 1H), 7.12 (dd, J = 8.2, 1.2 Hz, 1H), 7.02 (dd, J 
= 7.9, 1.6 Hz, 1H), 4.86 (s, 1H), 2.16 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.2, 
142.6, 129.5, 128.9, 128.7, 128.6, 127.4, 126.7, 125.5, 119.4, 65.3, 28.9. The ee value 
was 99.6%, tR (minor) = 15.7 min, tR (major) = 21.2 min (Chiralpak IC, λ = 220 nm, 
hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd for 












Enantiomerically enriched 2-20bm 
 
 
Compound 2-20bn. A colorless solid. []25D +17 (c 0.57, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.33 (td, J = 7.5, 1.4 Hz, 1H), 7.23 (d, J = 8.2 Hz, 2H), 7.17 (d, J = 7.3 Hz, 
2H), 7.16 (t, J = 6.4 Hz, 1H), 7.10 (d, J = 8.3 Hz, 1H), 7.00 (d, J = 7.9 Hz, 1H), 4.86 
(s, 1H), 2.34 (s, 3H), 2.14 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.1, 140.7, 138.5, 
129.5, 129.4, 128.6, 127.5, 126.6, 125.5, 119.3, 65.1, 28.8, 21.0. The ee value was 
98.1%, tR (minor) = 16.9 min, tR (major) = 22.7 min (Chiralpak IC, λ = 220 nm, 
hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd for 














Compound 2-20bo. A colorless solid. []25D +6 (c 0.83, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.61–7.55 (m, 4H), 7.48–7.41 (m, 4H), 7.40–7.33 (m, 2H), 7.21 (td, J = 7.7, 
1.2 Hz, 1H), 7.12 (dd, J = 8.3, 0.9 Hz, 1H), 7.10 (dd, J = 7.9, 1.5 Hz, 1H), 5.04 (s, 
1H), 2.18 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.2, 142.4, 141.5, 140.0, 129.6, 
128.8, 128.6, 127.7, 127.5, 127.3, 127.2, 127.1, 125.6, 119.4, 65.1, 29.0. The ee value 
was 98.8%, tR (minor) = 22.1 min, tR (major) = 35.6 min (Chiralpak IC, λ = 254 nm, 
hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd for 








Enantiomerically enriched 2-20bo 
 
 
Compound 2-20bp. A colorless solid. []25D +20 (c 0.53, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.33 (td, J = 7.5, 1.5 Hz, 1H), 7.26 (d, J = 8.8 Hz, 2H) , 7.16 (td, J = 7.5, 1.1 
Hz, 1H), 7.10 (d, J = 8.2 Hz, 1H), 7.00 (dd, J = 7.9, 1.5 Hz, 1H), 6.86 (d, J = 8.9 Hz, 
2H), 4.86 (s, 1H), 2.80 (s, 3H), 2.13 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 159.5, 
150.1, 135.7, 129.4, 128.6, 128.1, 127.6, 125.5, 119.3, 114.0, 64.9, 55.3, 28.9. The ee 
value was 99.9%, tR (minor) = 31.3 min, tR (major) = 37.3 min (Chiralpak IC, λ = 220 
nm, hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd for 





 Racemic 2-20bp 
 
 






Compound 2-20bq. A colorless solid. []25D +9 (c 0.63, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.38–7.32 (m, 3H), 7.29 (d, J = 8.8 Hz, 2H), 7.19 (t, J = 7.2 Hz, 1H), 7.14 (t, 
J = 7.4 Hz, 1H), 7.10 (d, J = 8.2 Hz, 1H), 7.06 (dd, J = 7.9, 1.4 Hz, 1H), 7.02 (d, J = 
7.8 Hz, 2H), 6.95 (d, J = 8.8 Hz, 2H), 4.98 (s, 1H), 2.13 (s, 3H). 13C NMR (125 MHz, 
CDCl3) δ 157.7, 156.2, 150.2, 137.9, 129.9, 129.6, 128.6, 128.3, 127.3, 125.5, 122.9, 
119.5, 119.4, 118.3, 64.9, 29.2. The ee value was 98.6 %, tR (minor) = 20.5 min, tR 
(major) = 25.3 min (Chiralpak IC, λ = 254 nm, hexane/i-PrOH = 9/1, flow rate = 1.0 
mL/min). HRMS (ESI) m/z calcd for C20H17NO4S (M-H) 366.0806, found 366.0802. 
 





Enantiomerically enriched 2-20bq 
 
 
Compound 2-20br. A colorless solid. []25D +34 (c 0.68, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.36 (td, J = 7.9, 1.7 Hz, 1H), 7.33 (dd, J = 9.0, 5.2 Hz, 2H), 7.21 (td, J = 
7.7, 1.2 Hz, 1H), 7.09 (dd, J = 7.3, 1.1 Hz, 1H), 7.07 (dd, J = 7.8, 1.4 Hz, 1H), 7.04 (t, 
J = 8.6 Hz, 2H), 5.08 (s, 1H), 2.10 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 162.4 (d, 
JF-C = 249 Hz), 150.1, 139.2 (d, JF-C = 3 Hz), 129.7, 128.7 (d, JF-C = 8 Hz), 128.4, 
127.0, 125.6, 119.5, 115.6 (d, JF-C =22 Hz), 64.7, 29.6. The ee value was 98.4%, tR 
(minor) = 14.8 min, tR (major) = 18.0 min (Chiralpak IC, λ = 220 nm, hexane/i-PrOH 












Enantiomerically enriched 2-20br 
 
 
Compound 2-20bs. A colorless solid. []25D +27 (c 0.53, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.37 (td, J = 7.8, 1.6 Hz, 1H), 7.32 (d, J = 8.8 Hz, 2H), 7.28 (d, J = 8.8 Hz, 
2H), 7.22 (td, J = 7.7, 1.2 Hz, 1H), 7.11 (dd, J = 8.3, 1.1 Hz, 1H), 7.07 (dd, J = 7.9, 
1.5 Hz, 1H), 4.95 (s, 1H), 2.10 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.2, 141.8, 
134.5, 129.8, 128.9, 128.3, 128.2, 126.7, 125.6, 119.6, 64.7, 29.6. The ee value was 
99.4%, tR (minor) = 14.3 min, tR (major) = 18.2 min (Chiralpak IC, λ = 220 nm, 











Enantiomerically enriched 2-20bs 
 
 
Compound 2-20bt. A colorless solid. []25D +23 (c 0.71, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.48 (d, J = 8.7 Hz, 2H), 7.37 (td, J = 7.5, 1.6 Hz, 1H), 7.22 (d, J = 8.6 Hz, 
2H), 7.22 (td, J = 8.7, 1.2 Hz, 1H), 7.12 (dd, J = 8.3, 1.1 Hz, 1H), 7.06 (dd, J = 7.9, 
1.5 Hz, 1H), 4.90 (s, 3H), 2.09 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.2, 142.3, 
131.9, 129.9, 128.5, 128.3, 126.6, 125.6, 122.8, 119.6, 64.8, 29.5. The ee value was 
99.9%, tR (minor) = 15.7 min, tR (major) = 20.0 min (Chiralcel IC, λ = 220 nm, 












Enantiomerically enriched 2-20bt 
 
 
Compound 2-20bu. A colorless solid. []25D +63 (c 0.34, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.61 (d, J = 8.4 Hz, 2H), 7.49 (d, J = 8.4 Hz, 2H), 7.40 (td, J = 8.1, 1.4 Hz, 
1H), 7.26 (td, J = 7.7, 1.2 Hz, 1H), 7.14 (dd, J = 7.8, 1.5 Hz, 1H), 7.12 (d, J = 7.8 Hz, 
1H), 5.11 (s, 1H), 2.10 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.3, 146.9, 130.6 (q, 
JF-C = 33 Hz), 130.1, 128.3, 127.2, 126.3, 125.7, 125.7 (q, JF-C = 4 Hz), 122.8 (q, JF-C 
= 272 Hz), 119.7, 64.8, 30.0. The ee value was 99.4%, tR (minor) = 12.3 min, tR 
(major) = 17.0 min (Chiralpak AD-H, λ = 220 nm, hexane/i-PrOH = 9/1, flow rate = 



















Compound 2-20bv. A colorless solid. []25D +6 (c 0.53, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.33 (td, J = 7.8, 1.6 Hz, 1H), 7.25 (td, J = 7.8, 1.6 Hz, 1H), 7.18–7.15 (m, 
3H), 7.14 (s, 1H), 7.11 (dd, J = 8.3, 1.2 Hz, 1H), 7.00 (dd, J = 7.9, 1.6 Hz, 1H), 4.87 
(s, 1H), 2.34 (s, 3H), 2.15 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.1, 142.6, 138.7, 
129.37, 129.36, 128.7, 128.6, 127.5, 127.3, 125.5, 122.7, 119.3, 65.2, 28.7, 21.5. The 
ee value was 99.4%, tR (minor) = 14.4 min, tR (major) = 18.8 min (Chiralpak IC, λ = 
220 nm, hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd for 














Compound 2-20bw. A colorless solid. []25D +18 (c 0.55, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.33 (td, J = 7.5, 1.6 Hz, 1H), 7.28 (t, J = 8.0 Hz, 1H), 7.17 (td, J = 7.7, 1.2 
Hz, 1H), 7.10 (dd, J = 8.3, 1.1 Hz, 1H), 7.03 (dd, J = 7.9, 1.5 Hz, 1H), 6.97–6.88 (m, 
2H), 6.86 (dd, J = 8.2, 2.4 Hz, 1H), 4.92 (s, 1H), 2.78 (s, 3H), 2.13 (s, 3H). 13C NMR 
(125MHz, CDCl3) δ 159.8, 150.1, 145.2, 130.0, 129.5, 128.6, 127.3, 125.5, 119.4, 
118.9, 112.32, 112.27, 65.2, 55.3, 28.8. The ee value was 99.9%, tR (minor) = 21.5 
min, tR (major) = 28.9 min (Chiralpak IC, λ = 220 nm, hexane/i-PrOH = 9/1, flow rate 















Compound 2-20bx. A colorless solid. []25D +31 (c 0.81, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ7.33 (td, J = 7.8, 1.6 Hz, 1H), 7.31 (s, 1H), 7.287.24 (m, 2H), 7.22 (t, J = 
8.3 Hz, 1H), 7.20 (td, J = 7.6, 1.4 Hz, 1H), 7.08 (dd, J = 9.5, 1.2 Hz, 1H), 7.06 (dd, J 
= 7.9, 1.4 Hz, 1H), 5.05 (s, 1H), 2.07 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.2, 
145.3, 134.7, 130.0, 129.9, 128.7, 128.4, 127.0, 126.4, 125.7, 125.0, 119.6, 64.8, 29.5. 
The ee value was 99.7%, tR (minor) = 12.7 min, tR (major) = 20.5 min (Chiralpak IC, 
λ = 220 nm, hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd 







Enantiomerically enriched 2-20bx 
 
 
Compound 2-20by. A colorless solid. []25D +22 (c 1.0, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.33 (td, J = 7.8, 1.5 Hz, 1H), 7.18 (td, J = 7.7, 1.2 Hz, 1H), 7.09 (dd, J = 
8.2, 1.0 Hz, 1H), 7.04 (dd, J = 7.9, 1.6 Hz, 1H), 6.81 (s, 1H), 6.80 (dd, J = 7.4, 1.7 Hz, 
1H), 6.75 (dd, J = 7.4, 1.5 Hz, 1H), 5.96 (s, 2H), 4.94 (s, 1H), 2.09 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 150.1, 148.1, 147.7, 137.5, 129.6, 128.5, 127.5, 125.6, 120.4, 
119.4, 108.1, 107.5, 101.5, 65.2, 29.1. The ee value was 99.9%, tR (minor) = 32.7 min, 












Enantiomerically enriched 2-20by 
 
 
Compound 2-20bz. A colorless solid. []25D 85 (c 0.64, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.63 (dd, J = 6.9, 2.3 Hz, 1H), 7.31-7.27 (m, 3H), 7.16 (dd, J = 6.3, 2.5 Hz, 
1H), 7.10 (td, J = 7.5, 1.2 Hz, 1H), 7.07 (dd, J = 8.2, 1.0 Hz, 1H), 6.82 (dd, J = 7.8, 
1.5 Hz, 1H), 4.92 (s, 1H), 2.23 (s, 3H), 2.05 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
149.8, 140.4, 136.7, 132.6, 129.3, 129.2, 127.8, 127.5, 126.8, 126.3, 125.9, 117.0, 
65.0, 29.5, 20.6. The ee value was 99.9%, tR (minor) = 11.6 min, tR (major) = 16.6 
min (Chiralpak IC, λ = 220 nm, hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). 







Enantiomerically enriched 2-20bz 
 
 
Compound 2-20cm. A colorless solid. []25D +9 (c 0.78, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.41–7.32 (m, 5H), 7.30 (tt, J = 7.0, 1.2 Hz, 1H), 7.22 (td, J = 7.7, 1.2 Hz, 
1H), 7.14 (dd, J = 7.9, 1.5 Hz, 1H), 7.12 (dd, J = 8.2, 1.2 Hz, 1H) , 5.01 (s, 1H), 2.45 
(dq, J = 14.5, 7.2 Hz, 1H), 2.40 (dq, J = 14.8, 7.4 Hz, 1H), 1.01 (t, J = 7.3 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ 150.8, 142.4, 129.5, 128.5, 128.4, 128.1, 126.7, 125.7, 
125.3, 119.5, 68.4, 34.5, 8.6. The ee value was 99.5%, tR (minor) = 15.8 min, tR 











Enantiomerically enriched 2-20cm 
 
 
Compound 2-20cn. A colorless solid. []25D +3 (c 1.1, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.34 (td, J = 8.0, 1.4 Hz, 1H), 7.26 (d, J = 8.1 Hz, 2 H), 7.20 (t, J = 7.7 Hz, 
1H), 7.16 (d, J = 8.1 Hz, 2H), 7.14–7.10 (m, 2H), 4.98 (s, 1H), 2.45 (dq, J = 14.8, 7.2 
Hz, 1H), 2.40 (dq, J = 14.9, 7.5 Hz, 1H), 2.34 (s, 3H), 1.02 (t, J = 7.3 Hz, 3H). 13C 
NMR (125 MHz, CDCl3) δ 150.7, 139.5, 138.0, 129.4, 129.3, 128.4, 126.7, 126.1, 
125.3, 119.5, 68.3, 34.2, 21.0, 8.7. The ee value was 99.5%, tR (minor) = 15.2 min, tR 
(major) = 29.2 min (Chiralpak IC, λ = 220 nm, hexane/i-PrOH = 9/1, flow rate = 1.0 







Enantiomerically enriched 2-20cn 
 
 
Compound 2-20dm. A colorless solid. []25D +21 (c 0.53, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.40– 7.32 (m, 5H), 7.30 (tt, J = 6.8, 1.5 Hz, 1H), 7.23 (td, J = 7.7, 1.3 Hz, 
1H), 7.15 (dd, J = 7.9, 1.6 Hz, 1H), 7.11 (dd, J = 8.2, 1.2 Hz, 1H), 5.02 (s, 1H), 2.34 (t, 
J = 7.1 Hz, 2H), 1.47–1.19 (m, 6H), 0.87 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 150.7, 142.7, 129.5, 128.5, 128.4, 128.1, 126.7, 125.8, 125.3, 119.6, 68.1, 




= 12.6 min (Chiralpak IC, λ = 220 nm, hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). 








Enantiomerically enriched 2-20dm 
 
Compound 2-20ep. A colorless solid. []25D +2 (c 1.0, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.37 (td, J = 7.8, 1.6 Hz, 1H), 7.17m, 6H), 7.13 (d, J = 9.0 Hz, 2H), 
7.09 (d, J = 8.4 Hz, 2H), 6.86 (td, J = 7.7, 1.3 Hz, 1H), 6.86 (d, J = 8.9 Hz, 2H), 5.46 
(s, 1H), 2.81 (s, 3H), 2.36 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 159.4, 150.6, 139.4, 
138.4, 134.1, 130.8, 129.8, 129.7, 129.2, 128.2, 127.3, 124.7, 119.4, 112.7, 71.6, 55.3, 
21.0. The ee value was 99.2%, tR (minor) = 50.9 min, tR (major) = 54.2 min 
(Chiralpak AD-H, λ = 220 nm, hexane/i-PrOH = 19/1, flow rate = 1.0 mL/min). 














Compound 2-20fp. A colorless solid. []25D 5 (c 0.54, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.38 (td, J = 7.1, 1.5 Hz, 1H), 7.38–7.35 (m, 3H), 7.25–7.22 (m, 2H), 7.16 
(dd, J = 8.3, 1.0 Hz, 1H), 7.15 (td, J = 7.5, 1.2 Hz, 1H), 7.12 (d, J = 8.9 Hz, 2H), 6.87 
(d, J = 8.9 Hz, 2H), 6.85 (dd, J = 7.0, 2.0 Hz, 1H), 5.44 (s, 1H), 2.81 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 159.5, 150.7, 142.3, 134.1, 130.8, 129.9, 129.7, 128.49, 
128.47, 128.36, 127.0, 124.8, 119.5, 112.8, 71.7, 55.2. The ee value was 99.6%, tR 
(minor) = 52.4 min, tR (major) = 59.7 min (Chiralpak AD-H, λ = 220 nm, 
hexane/i-PrOH = 19/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd for 








Enantiomerically enriched 2-20fp 
 
 
Compound 2-20gp. A colorless solid. []25D +7 (c 1.1, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ 7.37 (td, J = 7.8, 1.6 Hz, 1H), 7.23 (t, J = 7.7, 1H), 7.16–7.13 (m, 3H), 7.13 
(d, J = 8.9 Hz, 2H), 7.03 (s, 1H), 6.97 (d, J = 7.9 Hz, 1H), 6.87 (d, J = 8.9 Hz, 2H), 
6.85 (dd, J = 6.3, 1.6 Hz, 1H), 5.45 (s, 1H), 2.81 (s, 3H), 2.32 (s, 3H). 13C NMR (125 
MHz, CDCl3) δ 159.4, 150.6, 142.5, 138.3, 134.0, 130.8, 129.8, 129.3, 128.8, 128.3, 
127.2, 125.5, 124.8, 119.5, 112.7, 105.0, 71.7, 55.3, 21.6. The ee value was 96%, tR 




hexane/i-PrOH = 19/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd for 
C21H19NO4S (M-H) 380.0962, found 380.0956. 
 Racemic 2-20gp 






Compound 2-20gn. A colorless solid. []25D 2 (c 0.84, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ7.37 (td, J = 7.8, 1.5 Hz, 1H), 7.23 (t, J = 7.7 Hz, 1H), 7.19–7.13 (m, 3H), 
7.16 (d, J = 7.9 Hz, 2H), 7.10 (d, J = 8.3 Hz, 2H), 7.03 (s, 1H), 6.97 (d, J = 7.9 Hz, 
1H), 6.86 (dd, J = 7.8, 1.4 Hz, 1H), 5.46 (s, 1H), 2.36 (s, 3H), 2.32 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 150.6, 142.3, 139.2, 138.3, 138.3, 130.9, 129.8, 129.3, 129.1, 
128.9, 128.34, 128.28, 127.0, 125.6, 124.8, 119.5, 71.9, 21.6, 21.0. The ee value was 
97%, tR (minor) = 12.2 min, tR (major) = 16.4 min (Chiralpak IC, λ = 220 nm, 
hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). HRMS (ESI) m/z calcd for 









Enantiomerically enriched 2-20gn 
 
 





Transformation of 2-20cn to 4-20cn: The reaction was carried out according to the 
procedures reported for .[72b] To a suspension of lithium aluminium hydride (12 mg, 
0.30 mmol) in THF (2.0 mL) was added 2-20cn (30.3 mg. 0.100 mmol, 99.5% ee), 
and the mixture was stirred under reflux for 6 h. The mixture was cooled to 0 °C, and 
water (60 µL) and 10% NaOH (20 µL) was carefully added. The resulting mixture 
was stirred at the same temperature for 30 min, and it was passed through a short 
column of celite with ethyl acetate as an eluent. The solvent was removed on a rotary 
evaporator and the residue was subjected to flash chromatography on silica gel using 
hexane/ethyl acetate (6:1) as an eluent to give 4-20cn as a colorless solid (19.4 mg, 81% 
yield, 99.4% ee).   
 
In a similar manner, treatment of 2-20gn with lithium aluminium hydride in THF gave 
75% yield of 2-21gn.   
 
 
Compound 2-21cn. A colorless solid. []25D +20 (c 0.85, CHCl3). 1H NMR (500 MHz, 




6.93 (d, J = 7.7 Hz, 1H), 6.82 (d, J = 8.1 Hz, 1H), 6.74 (t, J = 7.5 Hz, 1H), 2.39–2.19 
(m, 2H), 2.32 (s, 3H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 158.0, 
136.5, 129.3, 129.1, 128.9, 128.1, 126.7, 125.7, 118.5, 117.7, 62.8, 34.1, 20.9, 8.4. 
The ee value was 99.4%, tR (minor) = 21.9 min, tR (major) = 41.2 min (Chiralcel 
OD-H, λ = 220 nm, hexane/i-PrOH = 7/3, flow rate = 0.5 mL/min). HRMS (ESI) m/z 
calcd for C16H19NO (M-H) 240.1394, found 240.1397. 






Enantiomerically enriched 2-21cn 
 
Compound 2-21gn. A colorless oil. []25D 0.4 (c 1.0, CHCl3).1H NMR (500 MHz, 
CDCl3) δ 7.217.09 (m, 5H), 6.99 (d, J = 8.1 Hz, 2H), 6.96 (s, 1H), 6.88 (d, J = 8.2 
Hz, 2H), 6.69 (t, J = 7.5 Hz, 1H), 6.55 (d, J = 7.8 Hz, 1H), 2.35 (s, 3H), 2.30 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 158.1, 137.8, 136.9, 130.4, 130.3, 130.0, 129.3, 129.2, 
128.9, 128.2, 128.1, 128.0, 127.5, 124.9, 118.3, 117.6, 67.1, 21.6, 21.0. The ee value 
was 97%, tR (minor) = 12.3 min, tR (major) = 15.8 min (Chiralcel OD-H, λ = 220 nm, 
hexane/i-PrOH = 7/3, flow rate = 0.5 mL/min). HRMS (ESI) m/z calcd for C21H21NO 











Chapter 3 Palladium(II)/PHOX Complex-Catalyzed 
Asymmetric Addition of Boron Reagents to Cyclic 
Trifluoromethyl Ketimines: An Efficient Preparation 
of Anti-HIV Drug Analogues 
 
3.1 Introduction  
Chiral nitrogen-containing compounds are widely distributed in nature and 
include many bioactive molecules. Among all of these compounds, 
dihydroquinazolines are taken as an important class of heterocyclic compounds due to 
their intriguing biological properties, such as antiviral, antiobesity activities and their 
use in the treatment in the cardiovascular diseases.80 Notably, DPC 961 and DPC 083 
of this class are second-generation HIV nonnucleoside reverse transcriptase inhibitors 
(NNRTIs) with enhanced potency when compared to Efavirenz (Sustiva) (Scheme 
3.1).81 Therefore, enatioselectively synthesizing DPC 961 and DPC 083 analogues in 
efficient way has been attracting synthetic chemists since their high biological 
performances were discovered. 
                                                             
80 a) J. W. Corbett, Curr. Med. Chem.: Anti-Infect.Agents 2002, 1, 119；b) S. G. Mueller, K. Rudolf, P. 
Lustenberger, D. Stenkamp, K.Arndt, H. Doods, G. Schaenzle, U.S. Pat. 20050234054, 2005; c) H. Hasegawa, M. 
Muraoka, K. Matsui, A. Kojima, Bioorg. Med. Chem. Lett. 2003, 13, 3471. 
81 J. W. Corbett, S. S. Ko, J. D. Rodgers, L. A. Gearhart, N. A.Magnus, L. T. Bacheler, S. Diamond, S. Jeffrey, R. 
M. Klabe, B. C.Cordova, S. Garber, K. Logue, G. L. Trainor, P. S. Anderson, S. K. Erickson-Viitanen, J. Med. 





Scheme 3.1 Structures of Efavirenz, DPC 961 and DPC 083 
 
In 2004 Jiang group reported the first example of using achiral substrate 3-1a to 
directly obtain DCP 961 and its analogues and stoichiometric amount of Zn(OTf)2 and 




















up to 96% yield







  Scheme 3.2 Zn(OTf)2 promoted asymmetric alkynylation of ketimine 
 
Comparing with the metal-promoted reaction, organocatalysis was much more 
investigated to synthesize important intermediates of DPC 083 by applying different 
nucleophiles and activate models. Jiang group in 2008 demonstrated a high 
enantioselective construction of a quaternary carbon center of dihydroquinazoline 3-6 
by an organocatalytic Mannich reaction with 30 mol% L-proline derivatives 3-7 or 
                                                             












































Scheme 3.3 Proline catalyzed asymmetric Mannich reaction of alkyl ketone and ketimine 
 
Later on, Wang and coworkers developed a bifunctional cinchona alkaloid 
thiourea 3-11 catalyzed high efficient and enatioselective aza-Henry reaction of the 
cyclic trifluoromethyl ketimines 3-1 which served as a key step in the preparation of 
anti-HIV drug DPC 083 in 2011(Scheme 3.4).84 
                                                             
83 B. Jiang, J. J. Dong, Y. G. Si, X. L. Zhao, Z. G Huang, M Xu, Adv. Synth. Catal. 2008, 350, 1360. 




































































































Scheme 3.4 Bifunctional cinchona thiourea catalyzed asymmetric aza-Henry reaction of 
ketimines and derivation to DPC 083 
 
In the recent two years, Ma group6 mainly worked on the important starting 
cyclic ketimine substrates and designed various organocatalyitic asymmetric reactions 
based on hydrogen bond activation to achieve the anti-HTV drug analogues, such as 
Strecker reaction(2012), 85  decarboxylative Mannich reaction(2013) 86  and 
                                                             
85 F.-G. Zhang, X.-Y. Zhu, S. Li, J. Nie, J.-A. Ma, Chem. Commun. 2012, 48, 11552. 




aza-Friedel-Crafts reaction(2013)87 (Scheme 3.5).  
 
  
                                                             


















cat. 3-21 (5 mol%)






up t0 98% yield












Scheme 3.5 Ma’s work on asymmetric reactions of ketimines and synthesis of DPC 083 
 
From the above review, it can be generalize that most reported methods to 
synthesize anti-HIV drug analogues mainly focused on organo-catalytic asymmetric 
reactions. On the other hand, there was one only report about direct synthesis of DPC 
961 analogues by metal promoted nucleophilic asymmetric addition to 
dihydroquinazolines. However，a stoichiometric amount catalyst loading was crucial 
to this chemical transformation.  
Recently palladium-and Rhodium-catalyzed asymmetric additions of imines 
have emerged as a very important tool for generating disustituted and trisubstituted 
amines with stereogenic carbon center.[66] Our lab also reported the high performance 
of a palladium-PHOX catalyst in asymmetric arylation of cyclic N-sulfonyl 
ketimines. 88    To the best of our knowledge, no transition-metal-catalyzed 
asymmetric addition of cyclic trifluoromethyl ketimines was reported so far. Herein, 
we intend to apply transition-metal catalytic system in this transformation to obtain 
anti-HIV drug analogues.  
 
                                                             




3.2 Results and discussions 
 
3.2.1 Catalyst screening 
During our study on the catalytic asymmetric addition of organoboron reagents to 
cyclic trifluoromethyl ketimines 3-1, it was found that the cationic palladium 
complex coordinated with a chiral phosphine-oxazoline ligand, which was proved to 
be efficient catalyst in asymmetric arylation of N-sulfonyl ketimines,89 showed high 
catalytic activity and high enantioselectivity in the asymmetric addition of 
arylboronic acids to cyclic trifluoromethyl ketimines 3-1 to afford high yields of 
chiral dihydroquinazolines 3-23 which bear tetra-substituted stereogenic center. 
We selected the asymmetric reaction of phenyl boronic acid 3-22m to 
6-chloro-1-(4-methoxybenzyl)-4-(trifluoromethyl)quinazolin-2(1H)-one 3-1a as one 
of the model reactions,  and a number of transition-metal catalytic systems were 
screened. The results are shown in Table 3.1. 
Table 3.1 Catalytic Asymmetric Addition of Phenylboronic Acid to Cyclic N-trifluoromethyl 
kestimine [a] 
                                                             





 Cat. (5 mol%) 
additive 
Solvent 














90 99.8, R 














K3PO4, t-amyl alcohol 
dioxane 
60, 12 
67 93, R 









99 99.8, R 
[a] Reaction conditions: 3-1a (0.10 mmol), 3-22m (0.20 mmol), catalyst (5 mol%), additive, solvent 
(1.0 mL) at a given temperature for 12 h. [b] Isolated yield of 3-23am. [c] Determined by HPLC 
analysis with chiral columns. The absolute configuration of 3-23am was determined by X-ray 
crystallographic analysis. [d] Catalyst (1 mol%) and additive (3 mol%) were employed. 
 
The palladium-phosphineoxazoline complex with AgBF4 as additive was firstly 
employed in this reaction. Excitingly, both excellent yield and ee were obtained 
under this catalytic system (entry 1). Less reactive additive AgOTf with Pd complex 
can also catalyze the transformation in lower yield (90%) and excellent ee (99.8%) 
(entry 2). It was found that generation of cationic palladium species is essential for 
the high catalytic activity. In the absence of AgBF4, no additive product was 
observed(entry 3). To compare palladium-PHOX complex with other catalysts, those 
for the reaction in the presence of other palladium and rhodium complexes so far 
reported as effective catalysts were also examined. Palladium complex coordinated 
with chiral oxazoline-pyridine ligands can only give modest yield (42%) even 
though with good enanotioselectivity (89% ee) (entry 4). Chiral Pd/BINAP system 
can not afford the desired product 3-23am (entry 5). Chiral diene/rhodium catalyst, 
which was previously reported to be an efficient catalyst in asymmetric additions of 




give product of high ee (93%) in a moderate yield (67%) (entry 6). Owing to high 
catalytic abitility of Pd/PHOX complex, the reaction was further performed under 
room temperature, the enantioselectivity remained (99.8%) but yield dropped (50%) 
(entry 7). We were delighted to find the reaction proceed smoothly under 1 mol% 
catalyst loading under 65-70 oC (entry 8).  
 
3.2.2 Substrate scope 
With the optimized condition in hand, we next studied the substrate scope of 
asymmetric addition of an array of different arylboronic acids 3-22 to the 
dihydroquinazoline 3-1a. 
 
Table 3.2 Catalytic Asymmetric Addition of Arylboronic Acid 3-22 to Cyclic 
N-trifluoromethyl ketimine 3-1a [a] 
 
 











3-23an, 99 99.5, R 
3 AgBF4 
3-22o 
3-23ao, 82 99.9, R 
4 AgBF4 
3-22p 
3-23ap, 99 99.9, R 
5 AgBF4 
3-22q 
3-23aq, 87 99.9, R 
6 AgBF4 
3-22r 
3-23ar, 42 99.9, R 















3-23aw, 53 99.8, R 
13 AgBF4 
3-22x 








(1.0 mL) at a given temperature for 12 h. [b] Isolated yield of 3-23. [c] Determined by HPLC analysis 
with chiral columns.  
 
The cationic palladium catalyst generated from PdCl2[(S)-i-Pr-phox] and AgBF4 
was found to have wide applicability in the asymmetric addition of arylboronic acids 
3-22 to the cyclic triflouromethyl ketimine 3-1a. The addition of phenylboronic acids 
substituted at para position with weak or strong electron-donating group methyl and 
methoxyl both gave the corresponding arylation products excellent enantioselectivity 
(99.5&99.9% ee) in excellent yield (99%) (entries 2 and 4). For those arylboronic 
acids which are with weak electron-withdrawing groups such as phenyl, bormo and 
chloro at para position, the enantioselectivity maintained very well (99.9% ee) but 
yields droped as electron-withdrawing abitlity increasing (enties 3, 5 and 6). For 
para-substituted bromo and strong trifluromethyl phenylboronic acids, the results 
were even worse and only trace amount of products can be observed (entries 89). 
Changing additive AgBF4 to a more reactive AgSbF6 could not influence the reactivity 
too much (entry 7). To our delight, under the standard condition both ortho- and 
meta-substituted phenylboronic acid with methyl group gave the product with high ee 
(99.9% and 99.8%) in moderate (53%) to excellent (99%) yields respectively (entries. 
12 and 10). From all of above results, it can be concluded that electron effects 
influence much more than steric effects in this transformation.It was found that the 
3,4-(Methylenedioxy)phenylboronic acid performed better than 




phenyl ring (entries 11 and 13). 1-Naphthylboronic acid was also tested and only low 
conversion (around 20%) to product can be afforded (entry 14).  
 
3.2.3 Determination of absolute configuration  
Furthermore, the absolute configuration of the product 3-23am was determined 
to be R by X-ray crystallographic analysis (Figure 3.1). 
 
Figure 3.1 ORTEP structure of dihydroquinazoline 3-23am 
 
3.3 Conclusion 
In conclusion, the first high ennatioselective asymmetric addition of organoboron 
reagents to cyclic trifluoromethyl ketamine catalyzed by chiral palladium complex 
was described. The synthetic methodology reported provides easy access to chiral 
dihydroquinazolines bearing tetra-substituted stereogenic center which are also 




and direct synthesis of DPC 083 by this method are in progress. 
 
3.4 Experimental section 
 
3.4.1 General Information 
All the starting materials were obtained from commercial sources and used 
without further purification unless otherwise stated. THF was dried and distilled 
from sodium benzophenone ketyl prior to use. DME and CH2Cl2 were distilled from 
CaH2 prior to use. 1H and 13C NMR spectra were recorded on a Bruker AMX500 
(500 MHz) spectrometer. Chemical shifts were reported in parts per million (ppm), 
and the residual solvent peak was used as an internal reference: proton (chloroform δ 
7.26), carbon (chloroform δ 77.0). Multiplicity was indicated as follows: s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), and br s 
(broad singlet). Coupling constants were reported in Hertz (Hz). Low resolution 
mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI mode, and 
a Agilent Tech. 5975C inert MSD. All high resolution mass spectra were obtained on 
a Finnigan/MAT 95XL-T spectrometer. For thin layer chromatography (TLC), 
Merck pre-coated TLC plates (Merck 60 F254) were used, and compounds were 
visualized with a UV light at 254 nm. Further visualization was achieved by staining 
with iodine, or ceric ammonium molybdate followed by heating on a hot plate. Flash 
chromatographic separations were performed on Merck 60 (0.040-0.063 mm) mesh 
silica gel. The Enantiomerically excesses of products were determined by 
chiral-phase HPLC analysis, using a Daicel Chiralpak IC column (250 x 4.6 mm). 
All the aryboronic acids are commercially available and used as received. The 
palladium complex PdCl2[(S)-iPr-phox]90 was prepared from PdCl2(MeCN)2 and 
                                                             




(S)-iPr-phox (CAS: 148461-14-7, Strem Chemicals Inc.) in benzene according to the 
reported procedure.90 
3.4.2 Synthesis of cyclic N-triflouromethyl ketimine 
Following the published procedure, we synthesized the ketimine 3-1a shown 
below.91 
 
1H NMR (500 MHz, CDCl3): δ 7.97 (s, 1H), 7.67 (dd, J = 9.0, 2.0 Hz, 1H), 7.37 (d, J 
= 9.0 Hz, 1H), 7.21 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 5.47 (s, 2H), 3.77 (s, 
3H). 
 
3.4.3 Palladium-catalyzed asymmetric arylation of ketimines 
                                                             
91 N. A. Magnus, P. N. Confalone, L. Storace, M. Patel, C. C. Wood, W. P. Davis, R. L. Parsons, Jr., J. Org. Chem. 





PdCl2[(S)-iPr-phox] (2.9 mg, 0.0050 mmol), ketimine xx (36.8 mg, 0.100 mmol), and 
benzeneboronic acid (2-19m) (24.4 mg, 0.200 mmol) were placed in Schlenk tube 
under nitrogen. To the tube, 1,2-dichloroethane (0.5 mL) was added, and then AgBF4 
(2.9 mg, 0.015 mmol) in 1,2-dichloroethane (0.5 mL) was added. The reaction 
mixture was stirred at 65–70 °C for 12 h, and the mixture was directly subjected to 
flash chromatography on silica gel using hexane/ethyl acetate (3:1) as an eluent to 
give 2-20bm as a colorless solid (44.6 mg, 99% yield). 
 
3.4.4 X-ray crystallographic analysis of 3-23am 
 





Table Crystal data 
Identification code  E352 
Empirical formula  C23 H18 Cl F3 N2 O2 
Formula weight  446.84 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 10.5894(4) Å 　= 90°. 
 b = 13.5143(5) Å 　 = 90°. 
 c = 28.9569(11) Å 　 = 90°. 
Volume 4144.0(3) Å3 
Z 8 
Density (calculated) 1.432 Mg/m3 
Absorption coefficient 0.234 mm-1 
F(000) 1840 
Crystal size 0.732 x 0.464 x 0.461 mm3 
Theta range for data collection 2.383 to 28.282°. 
Index ranges -14<=h<=13, -16<=k<=18, -38<=l<=36 
Reflections collected 36385 




Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6851 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10230 / 0 / 569 
Goodness-of-fit on F2 1.039 
Final R indices [I>2sigma(I)] R1 = 0.0299, wR2 = 0.0722 
R indices (all data) R1 = 0.0334, wR2 = 0.0741 
Absolute structure parameter -0.014(11) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.353 and -0.265 e.Å-3 
 
3.4.4 Analytical data of dihydroquinazoline 3-23 
 
 
Compound 3-23am.1H NMR (500 MHz, CDCl3) δ 7.58 (d, J = 6.9 Hz, 2H), 7.46–
7.39 (m, 3H), 7.18–7.13 (m, 3H), 6.85 (dd, J = 6.8, 4.7 Hz, 3H), 6.82 (d, J = 8.9 Hz, 
1H), 5.95 (s, 1H), 5.20 (d, J = 16.3 Hz, 1H), 5.04 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 158.86, 152.32, 137.81, 136.60, 130.12, 129.25, 




116.00, 114.27, 65.98, 65.75, 55.23, 45.53. The ee value was 99.8%, tR (major) = 
11.7 min, tR (minor) = 14.4 min (Chiralpak IC, λ = 254 nm, hexane/i-PrOH = 9/1, 







 Enantiomerically enriched 3-23am 
 
 
Compound 3-23an. 1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 7.9 Hz, 2H), 7.22 (d, 
J = 8.1 Hz, 2H), 7.14 (dd, J = 13.8, 5.2 Hz, 3H), 6.85 (d, J = 8.6 Hz, 3H), 6.81 (d, J 
= 8.9 Hz, 1H), 5.94 (s, 1H), 5.21 (d, J = 16.2 Hz, 1H), 5.03 (d, J = 16.3 Hz, 1H), 
3.78 (s, 3H), 2.38 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.81, 152.37, 139.24, 
136.56, 134.81, 130.02, 129.52, 129.17, 128.18, 127.68, 127.64, 127.44, 126.43, 
124.13, 120.95, 115.92, 114.22, 65.78, 65.55, 55.21, 45.50, 21.00. The ee value was 




hexane/i-PrOH = 95/5, flow rate = 1.0 mL/min). 
 





Enantiomerically enriched 3-23an 
 
Compound 3-23ao. 1H NMR (500 MHz, CDCl3) δ 7.65 (s, 4H), 7.61 (d, J = 7.4 Hz, 
2H), 7.47 (t, J = 7.6 Hz, 2H), 7.40 (t, J = 7.4 Hz, 1H), 7.17 (dd, J = 8.7, 3.6 Hz, 3H), 
6.90 (s, 1H), 6.84 (dd, J = 8.5, 7.3 Hz, 3H), 5.77 (s, 1H), 5.22 (d, J = 16.2 Hz, 1H), 
5.07 (d, J = 16.3 Hz, 1H), 3.77 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.88, 
152.28, 142.12, 139.69, 136.62, 136.57, 130.22, 129.15, 128.94, 128.69, 128.29, 
128.09, 127.96, 127.65, 127.63, 127.51, 127.13, 126.39, 124.10, 120.72, 116.07, 




tR (minor) = 44.0 min (Chiralpak IC, λ = 254 nm, hexane/i-PrOH = 9/1, flow rate = 
1.0 mL/min). 
 





Enantiomerically enriched 3-23ao 
 
Compound 3-23ap. 1H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 8.6 Hz, 2H), 7.14 (dd, 
J = 11.8, 5.3 Hz, 3H), 6.93 (d, J = 8.9 Hz, 2H), 6.87–6.77 (m, 4H), 5.93–5.85 (m, 
1H), 5.20 (d, J = 16.2 Hz, 1H), 5.03 (d, J = 16.2 Hz, 1H), 3.83 (s, 3H), 3.78 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 159.91, 158.82, 152.38, 136.56, 130.04, 129.67, 
129.19, 128.17, 127.64, 127.47, 126.46, 124.16, 121.11, 115.93, 114.24, 114.13, 
65.61, 65.38, 55.32, 55.22, 45.51. The ee value was 99.9%, tR (major) = 20.2 min, tR 













Enantiomerically enriched 3-23ap 
 
Compound 3-23aq. 1H NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 8.2, 5.1 Hz, 2H), 
7.19–7.07 (m, 5H), 6.88 – 6.82 (m, 2H), 6.80 (d, J = 10.1 Hz, 1H), 6.13 (s, 1H), 5.18 
(d, J = 16.2 Hz, 1H), 5.02 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 163.79, 161.80, 158.88, 152.33, 136.55, 133.69, 133.67, 130.28, 130.01, 
129.96, 129.02, 128.03, 127.65, 126.29, 124.00, 120.59, 116.10, 116.00, 115.83, 
114.26, 65.60, 65.37, 55.24, 45.54. The ee value was 99.8%, tR (major) = 12.1 min, 











Enantiomerically enriched 3-23aq 
 
Compound 3-23ar. 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.5 Hz, 2H), 7.41 (d, J 
= 8.7 Hz, 2H), 7.17 (dd, J = 8.9, 2.4 Hz, 1H), 7.14 (d, J = 8.6 Hz, 2H), 6.84 (t, J = 
9.3 Hz, 3H), 6.79 (s, 1H), 5.81 (s, 1H), 5.19 (d, J = 16.2 Hz, 1H), 5.03 (d, J = 16.3 
Hz, 1H), 3.78 (s, 3H). The ee value was 99.9%, tR (major) = 13.1 min, tR (minor) = 










Enantiomerically enriched 3-23ar 
 
 
Compound 3-23au. 1H NMR (500 MHz, CDCl3) δ 7.38 (d, J = 9.9 Hz, 2H), 7.31 (t, 
J = 7.6 Hz, 1H), 7.22 (d, J = 7.4 Hz, 1H), 7.20–7.12 (m, 3H), 6.85 (d, J = 8.8 Hz, 
3H), 6.82 (d, J = 8.9 Hz, 1H), 5.91 (s, 1H), 5.23 (d, J = 16.2 Hz, 1H), 5.03 (d, J = 
16.3 Hz, 1H), 3.78 (s, 3H), 2.38 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.82, 
152.33, 138.74, 137.70, 136.55, 130.07, 130.00, 129.20, 128.64, 128.50, 128.17, 




45.51, 21.59. The ee value was 99.9%, tR (major) = 19.4 min, tR (minor) = 21.7 min 
(Chiralpak IC, λ = 254 nm, hexane/i-PrOH = 95/5, flow rate = 1.0 mL/min). 
 





Enantiomerically enriched 3-23au 
 
Compound 3-23aw. 1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 7.1 Hz, 1H), 7.34 (t, 
J = 7.1 Hz, 1H), 7.29 (d, J = 7.5 Hz, 1H), 7.25 (d, J = 14.3 Hz, 1H), 7.20 (d, J = 8.7 
Hz, 2H), 7.16 (dd, J = 8.9, 2.3 Hz, 1H), 6.87 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.9 Hz, 
1H), 6.72 (s, 1H), 5.63 (s, 1H), 5.21 (d, J = 16.1 Hz, 1H), 5.10 (d, J = 16.2 Hz, 1H), 
3.78 (s, 3H), 2.05 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.87, 151.94, 138.37, 
137.07, 134.56, 134.10, 130.25, 129.60, 128.26, 128.24, 127.60, 127.57, 126.93, 




21.48. The ee value was 99.8%, tR (major) = 15.2 min, tR (minor) = 25.2 min 









Enantiomerically enriched 3-23aw 
 
Compound 3-23ax. 1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.6 Hz, 3H), 7.08 (d, 
J = 8.2 Hz, 1H), 7.00 (s, 1H), 6.88 (s, 1H), 6.85 (d, J = 8.6 Hz, 2H), 6.83–6.79 (m, 
2H), 6.00 (d, J = 2.4 Hz, 3H), 5.19 (d, J = 16.2 Hz, 1H), 5.02 (d, J = 16.3 Hz, 1H), 
3.77 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 158.83, 152.32, 148.21, 148.19, 136.49, 
131.31, 130.13, 129.04, 128.11, 127.64, 127.53, 126.32, 124.03, 121.53, 120.81, 
116.00, 114.24, 108.71, 108.04, 101.66, 65.81, 65.58, 55.22, 45.52. The ee value was 




hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). 
 








Chapter 4 Development of New Phosphine Ligands 
Derived from Amino Acids and  




The development of new chiral ligands always plays an important role in the 
discovery of asymmetric catalysts because the chiral ligands can support the metal 
ions and transfer their enantioselectivity in asymmetric reactions. Since its early 
invention of the chiral DIOP92 and DiPAMP93 ligands (Scheme 4.1), continuous 
efforts have been put into this area and many thousands of chiral ligands have been 
synthesized. However, the development of new chiral ligands still remains a great task 
for synthetic chemists even today. 
  
 
Scheme 4.1 Kagan’s DIOP and Knowles’ DiPAMP ligands 
 
                                                             
92 T. P. Dang, H. B. Kagan, J. Chem. Soc. Chem. Commun. 1971, 481. 





The process of discovering new chiral ligand is empirical, which means rational 
design, systematic screening, and even intuition and chance are all playing important 
roles. Meanwhile, most of the developed chiral ligands have been tested in many 
different types of asymmetric reactions, but only a few classes of chiral compounds 
were identified to keep their enantioselective ability in a wide range of different 
asymmetric reactions. These ligands are so-called “privileged ligands” (Scheme 
4.2).94 
 
Scheme 4.2 Examples of privileged chiral ligands 
 
It is noteworthy that among all of the “privileged ligands”, phosphine based 
ligands are attracting tremendous attention for they are the most efficient ligands for 
                                                             
94 a) T. P. Yoon, E. N. Jacobsen, Science 2003, 299, 1691; b) A. Pfaltz, W. J. Drury III, Proc. Natl. Acad. Sci. USA 




most homogeneous transition-metal catalysis. One of their advantages is that they can 
coordinate with the low-valent transition-metal intermediates and stabilize them to 
keep the high activity of catalysts which will influence the reaction efficiency in terms 
of catalytic activity and enantioselectivity.95 
On the other hand, amino acids are great naturally sources of chirality because 
they are readily available in enantiopure form, renewable and often of low cost. They 
have been employed as starting materials to produce many chiral compounds 
including the upper mentioned phosphine based ligands. One of the most famous 
ligand of them is phosphine-oxzazoline (PHOX ligand).96 The PHOX ligands are 
readily synthesized from the wide variety of commercial available amino alcohols and 
carboxylic acid derivatives, sharing scaffolds containing tri-aryl phosphines and 
oxzazoline rings. Although they were originally designed for Pd-catalyzed 
asymmetric allylic substitution, they have been proved to be remarkably versatile 
ligands in a wide range of metal-catalyzed asymmetric reactions. Another typical 
phosphine ligands derived from amino acids have similar phosphine structures as the 
classical DIOP ligand, which the di-aryl phosphine groups are readily introduced onto 
the chiral scaffolds of amino acids. As a matter of fact, these types of phosphine 
ligands were less developed comparing PHOX ligands even though they also have 
been reported for many years since their first discovery. One of the main possible 
reason is their structures are usually much more flexible than the other commonly 
used ligands, which makes the coordination between metals and ligands weak and 
                                                             
95 T. Hayashi, Acc. Chem. Res.2000, 33, 354. 




would further decreases both enantioselectivity and reaction efficiency (Scheme 4.3). 
One of the early studies of these flexible amino acid based phosphine ligands can be 
tracked back to Gilbertson’s work in 1994. Gilbertson and co-workers developed a 
phosphorous containing derivative and used it as a key motif in synthesis of 
phosphine containing peptide, coordinating with rhodium to form a new metal peptide 

























                                                             
97 a) S. R. Gilbertson, G. Chen, M. McLoughlin, J. Am. Chem. Soc. 1994, 116, 4481; b) S. R. Gilbertson, X Wang, 
J. Org. Chem. 1996, 61, 434; c) S. R. Gilbertson, G.W. Starkey, J. Org. Chem.1996, 61, 2922; d) S. R. Gilbertson, 
X . Wang, G. S. Hoge, C. Α. Klung, J. Schaefer, Organometallics.1996, 15, 6478; e) S. R. Gilbertson, G. Chen, J 
Kao, Α. Beatty, C.F. Campana, J. Org. Chem.1997, 62, 5557; f) S. R. Gilbertson; C. T. Chang, J. Org. Chem.1998, 
63, 8424; g) S. R. Gilbertson, D. Xie, Z. Fu, J. Org. Chem. 2000, 66, 7240; f) G. Xu; S. R. Gilbertson, 






















































Scheme 4.4 Gilbertson’s phosphorus containing peptide ligands 
 
Achiwa and co-workers in 1997 synthesized a new phosphorous containing 
amidine compound through several steps from L-valine, which was an excellent chiral 
ligand in the Pd-catalyzed asymmetric allylic alkylation (Scheme 4.5).98 
 
 Scheme 4.5 Achiwa’s phosphine-amidine ligand in Pd-catalyzed AAA reaction 
 
Later in 2000, Morimoto group modified the chiral amidine-phosphine ligand 
developed by Achiwa and produced a large library of these type bidentate ligands. 
                                                             




Furthermore, they studied the synthetic application and mechanism in the 
Pd-catalyzed asymmetric allylic substitutions (Sheme 4.6).99 
 
Scheme 4.6 Morimoto’s extension of Achiwa’s phosphine-amidine ligand 
 
Recently our group developed a new class of mono-phosphine catalysts which 
were proved to have excellent catalytic acitivity and enantioselectivity in many 
organo catalyzed asymmetric reactions.100 These catalysts are all derived from natural 
amino acids and have flexible long-chained structures with amide functional groups. 
Inspired by these high structure similarities with the reported amino acid derived 
phosphine ligands, we decided to bring these organocatalysts as well as design some 
new derivatives into the metal-catalyzed asymmetric reaction serving as ligand parters. 
To the best of our knowledge, no report has been published based on this proposed 
                                                             
99 A. Saitoh, K. Achiwa, K. Tanaka, T. Morimoto, J. Org. Chem. 2000, 65, 4227.  
100 a)X. Han, Y. Wang, F. Zhong, Y. Lu, J. Am. Chem. Soc. 2011, 133, 1726; b) F. Zhong, X. Han, Y. Wang, Y. Lu, 
Angew. Chem. Int. Ed. 2011, 50, 7837; c) F. Zhong, X. Han, Y. Wang, Y. Lu, Chem. Sci. 2012, 3, 1231; d) X Han, 





catalytic system so far. Herein, we developed a new type of phosphine ligand derived 
from amino acid and investigated its application in metal-catalyzed asymmetric 
reactions.  
 
4.2 Results and discussions 
 
4.2.1 Phosphine-amide ligands 
At the beginning of our study, various phosphine amide ligands were synthesized 












We chose the Pd-catalyzed asymmetric allylic alkylation between dimethyl 
malonate 4-13 and (E)-1,3-diphenylallyl acetate 4-14 as the first model reaction 
(Table 4.1). This reaction was started by preparing the racemic product in the presence 
of Pd(PPh3)4 and found the desired product could be obtained in 92% yield. Then 
ligand 4-1 and [Pd(3-C3H5)Cl]2 was chosen as the catalyst partners, but no desired 
product was observed. Later, we tested the other three similar phosphine ligands 4-2, 
4-3 and 4-4 derived from L-valine and L-threonine respectively, none of them can 
afford the desired product. The same disappointing result occurred in the presence of 
phosphoramidite ligand 4-8. Tri-aryl-phosphine based ligand 4-6 can finally give the 
product with around 60% conversion, but almost with no enatioselectivity. 
Bisphophine ligands 4-5 and 4-7 were also used to improve the binding ability 
between ligands and palladium catalyst. However, the conversion was kept in modest 
level and no essential improvement of enantioselectivity. 
 
Table 4.1 Phosphine ligands in Pd-catalyzed AAA reaction of malonate with allylic acetate[a]  
 
 Pd cat. Ligand  Convesion[b] 
[%] 
ee[c] [%] 
1 Pd(PPh3)4  92  




3 [Pd(3-C3H5)Cl]2 4-2 0  
4 [Pd(3-C3H5)Cl]2 4-3 0  
5 [Pd(3-C3H5)Cl]2 4-4 0  
6 [Pd(3-C3H5)Cl]2 4-5 50 10 
7 [Pd(3-C3H5)Cl]2 4-6 60 8 
8 [Pd(3-C3H5)Cl]2 4-7 67 30 
9 [Pd(3-C3H5)Cl]2 4-8 0  
[a] Reaction conditions: 4-14 (0.10 mmol), 4-13 (0.15 mmol), palladium catalyst (5 mol%), ligand 
(10 mol%), Cs2CO3 (1.2 eq) , THF (1.0 mL) at a room temperature for 24 h under Ar. [b] 
Determined by TLC . [c] Determined by HPLC analysis with chiral columns. 
 
After that, we changed the two reactants of allylic alkylation to -substituted 
nitrophosphonate 4-16 and allylic carbamate 4-17 (Table 4.2). For preparing racemic 
products, it was found Pd2(dba)3 is much more efficient than previous 
[Pd(3-C3H5)Cl]2, affording the phosphonate product 4-18 in full conversion. 
Nonetheless, the same problem occurred when chiral phosphine ligands were applied, 
only tri-aryl phosphine amide ligand 4-6 could promte the transformation in 90% 
conversion but with only 15% ee. To make a complete comparison, (R)-BINAP was 
also examined and lower yield and ee were observed. It was shown that -substituted 
nitrophosphonate is less reactive nucleophile possible owing to its steric hinder 





Table 4.2 Phosphine ligands in Pd-catalyzed AAA reaction of nitrophosphonate with allylic 
carbamate[a] 
 
 Pd cat. Ligand Conversion[b] 
[%] 
ee[c] [%] 
1 [Pd(3-C3H5)Cl]2 PPh3 50  
2 Pd2(dba)3 PPh3 100  
3 Pd2(dba)3 4-1 0  
4 Pd2(dba)3 4-2 0  
5 Pd2(dba)3 4-3 0  
6 Pd2(dba)3 4-6 90 15 
7 Pd2(dba)3 4-8 0  
8 Pd2(dba)3 4-9 0  
9 Pd2(dba)3 4-10 0  
10 Pd2(dba)3 4-12 0  
11 Pd2(dba)3 (R)-BINAP 30 8 
[a] Reaction conditions: 4-17 (0.10 mmol), 4-16 (0.12 mmol), palladium catalyst (5 mol%), ligand 
(10 mol%), THF (1.0 mL) at a room temperature for 24 h under Ar. [b] Determined by TLC . [c] 
Determined by HPLC analysis with chiral columns. 
 




nucleophile independently under Pd/phosphine amide catalytic system (Table 4.3 & 
4.4). Unfortunately, no essential change of either reactivity or enanotioselectivity was 
observed. All obtained results implied Pd-catalyzed allylic alkylation is not a good 
model reaction for testing phosphine-amide ligands. 
 
Table 4.3 Phosphine ligands in Pd-catalyzed AAA reaction of -fluoro--ketoester with 
allylic carbamate[a] 
 
 Pd cat. Ligand  Conversion[b] 
[%] 
ee [%] 
1 Pd(PPh3)4  95 0 
2 [Pd(3-C3H5)Cl]2 4-6 0  
3 [Pd(3-C3H5)Cl]2 4-11 0  
[a] Reaction conditions: 4-17 (0.10 mmol), 4-19 (0.12 mmol), palladium catalyst (5 mol%), ligand 
(10 mol%), THF (1.0 mL) at a room temperature for 24 h under Ar. [b] Determined by TLC. 
 






 Pd cat. Ligand  Conversion[b] [%] ee[c] [%] 
1 Pd(PPh3)4  90 0 
2 [Pd(3-C3H5)Cl]2 4-1 0  
3 [Pd(3-C3H5)Cl]2 4-2 0  
4 [Pd(3-C3H5)Cl]2 4-6 50 19 
5 [Pd(3-C3H5)Cl]2 4-9 0  
6 [Pd(3-C3H5)Cl]2 4-11 0  
7 Pd2(dba)3 4-1 0  
8 Pd2(dba)3 4-2 0  
9 Pd2(dba)3 4-9 0  
[a] Reaction conditions: 4-17 (0.10 mmol), 4-21 (0.12 mmol), palladium catalyst (5 mol%), ligand 
(10 mol%), THF (1.0 mL) at a room temperature for 24 h under Ar. [b] Determined by TLC . [c] 
Determined by HPLC analysis with chiral columns. 
 
Thus, we switched our interest onto silver-catalyzed enatioselective Mannich 
reaction of glycine derivatives 4-29 with imines 4-30 and a series of phosphine-amide 
ligands were examined (Table 4.5).The 3,5-di-trifluromethyl phenyl amide phosphine 




derivative 4-29 and tosyl imine 4-30 as substrates.To our delight, the reaction 
proceeded very well under this condition and more than 90% conversion was 
achieved, although with low disteroselctivity ( dr = 4.2:1) and enatioselctivity (12% 
ee). After that, two modified ligands 4-4 and 4-26 were tested to verify the steric 
effect. It was found that modification of amide group to peptide bi-functional ligand 
could remarkably increase the enantioselectivity. Some phosphine-peptide ligands 
were then synthesized to optimize reaction conditions. Among all of these 
phosphine-peptide ligands, ligand 4-23 could afford the best result (dr = 5.8:1, ee = 
81%). A phosphine-thiourea ligand 4-27 containing strong hydrogen bonding was also 
examined, but no desired product was achieved.  
 






 Ligand  Conversion[b] [%] dr[c] ee(major) [d] 
[%] 
1 PPh3 90   




3 4-4 90 4.8:1 13 
4 4-23 90 5.8:1 81 
5 4-24 90 4.1:1 63 
6 4-25 90 3.6:1 50 
7 4-26 90 3.0:1 43 
8 4-27 0  
9 4-28 90 4.5:1 61 
[a] Reaction conditions: 4-29 (0.10 mmol), 4-30 (0.12 mmol), silver catalyst (5 mol%), ligand (6 
mol%), THF (1.0 mL) at a room temperature for 24 h under Ar. [b] Determined by TLC. [c] 
Determined by 1H NMR. [d] Determined by HPLC analysis with chiral columns. 
 
4.4.2 Phosphine-olefin ligands 
In addition to above phosphine-amide type ligands, a class of phosphine ligands 



























Scheme 4.8 Phosphine-olefin ligands derived from amino acids 
 
Rh-catalyzed asymmetric 1,4-addition of organobronic acid to cycloenone 4-37 
were selected as a model reaction. Unfortunately, none of them could give the desired 
additive product under the standard condition (Table 4.6). By further NMR 
investigation, it implied that there was no coordination between olefin and rhodium 
catalyst, making the rhodium catalyst unstable in the reaction circumstance (Figure 
4.1). 
Table 4.6 Phosphine-olefin ligands in Rh-catalyzed 1,4-addition[a] 
 
 Ligand  Yield[b] [%] 
1 4-32 0 
2 4-33 0 
3 4-34 0 
4 4-35 0 
5 4-36 0 
[a] Reaction conditions: 4-37 (0.10 mmol), benzeneboronic acid (0.2 mmol), rhodium catalyst (5 
mol%), ligand (12 mol%), dioxane (1.0 mL) and KOH aq. (0.050 mmol, 0.1 mL) at 80 oC for 12 h 







Figure 4.1 31P NMR study on coordination between Rh catalyst and phosphine-olefin 
ligand 
 
The phosphine-olefin ligand 4-34 was tried in asymmetric allylic alkylation. 
However, no impressive result was obtained (Scheme 4.9). 
 
 
Scheme 4.9 Phosphine-olefin ligand in Pd-catalyzed AAA reaction 
 




Last but not least, we developed some phosphine-imine ligands inspired from 
Morimoto’s work in 2000. All of these phosphine-imine ligands could be easily 
derived from phosphine-amine precursors, leading to a facile modification of ligands. 
On account of the early applications of phosphine-imine ligands are Pd-catalyzed 
asymmetric allylic alkylations, we decided to select this reaction to test the reactivity 
of phosphine-imine ligands firstly. Substrates dimethyl malonate 4-13 and allyl 
acetate 4-14 could provide the diesired product with good yield (84%) and modest ee 
(53%) in the presence of [Pd(3-C3H5)Cl]2 and phosphine-imine ligand 4-39 under the 
standard condition. Interestingly, stable complex could generate between palladium 
catalyst precursor and phosphine-imine ligand 4-39 and the forming palladium 
complex 4-40 could also catalyze the transformation efficiently with approximate ee. 
Further optimizaiton of bulkyl group at -position even decreased the 
enantioselectivty (24% ee) (Scheme 4.10). 
 






Scheme 4.11 Pd/phosphine-imine complexes 
 
Pd-catalyzed asymmetric addition of imines is a well-established method for 
synthesizing chiral amine derivatives with tertiary or quaternary carbon center. We 
started screening the Pd/phosphine-imine complex 4-43 by using tosyl imines 4-46 as 
substrate for asymmetric phenylation. Desired adduct was obtained in 75% yield and 
74% ee (Scheme 4.12).  
+ PhB(OH)2
Pd cat. 2-43 (5 mol%)
AgBF4 (15 mol%)













Scheme 4.12 Pd/phosphine-imine complex catalyzed asymmetric arylation of tolsyl imine 
 
Meanwhile, N-sulfonyl cyclic imines were found to be less investigated in this 
transformation. Hence we decided to test the reactivity of Pd/phosphine-imine 
complexes for these cyclic imines. The results were summarized in Table 4.7. We 
were delighted to found complex 4-40 can well promote the transformation in modest 
yield (58%) and with best ee (81%) so far. Later the aryl groups of imine parts were 
modified. While two CF3 groups were introduced to meta-positions, catalytic activity 
increased dramatically (92% yield) but enatioselectivity slightly dropped (77% ee). it 
was also found that replacement of phenyl group by a bulky aryl group could increase 
the enatioselectivity and 1-naphanthyl 4-43 performed better for improving yield  
than 4-naphantyl group 4-44. Introducing a 9-anthracenyl group 4-45 caused almost 
no change about either activity or enatioselectivity. A further modification on 
-position by OTBDPS group 4-44 even decreased the ee.  
 
Table 4.7 Pd/phosphine-imine complex catalyzed asymmetric arylation of 6-membered 
cyclic imine[a] 
 
 Pd cat.  Yield[b] [%] ee[c] [%] 




2 4-41 92 77 
3 4-42 58 87 
4 4-43 98 91 
5 4-44 99 53 
6 4-45 98 92 
[a] Reaction conditions: 4-48(0.10 mmol), benzeneboronic acid (0.20 mmol), catalyst (5 mol%), 
AgBF4 (15 mol%), DCE (1.0 mL) at a given temperature for 12 h. [b] Isolated yield of 4-49. [c] 
Determined by HPLC analysis with chiral columns. 
Besides unsubstituted cyclic imines, other substituted cyclic imines were 
examined as well. The arylation of five-membered ring cyclic imine 4-50 proceeded 
efficiently by applying the best catalyst 4-43, providing the benzosultam 4-51 with 93% 
yield and 81% ee (Scheme 4.13). 
  
 
Scheme 4.13 Pd/phosphine-imine complex catalyzed asymmetric arylation of 
5-membered cyclic imine 
     
However, the methyl substituted six-membered ring one didn’t give any desired 




well-known PHOX ligand finding it is much more reactive comparing our developed 



























Scheme 4.14 Comparison between Pd/phosphine-imine and Pd/PHOX complexes 
 
4.3 Conclusion 
In conclusion, a series of phosphine-amide ligands, phosphine-olefin ligands and 
phosphine-imines ligands were prepared via a few steps from inexpensive amino 
acids. The applications of these new ligands in transition-metal-catalyzed asymmetric 
reactions were also examined. It was found that only a few of them can afford 
promising results, which are still not comparable with the reported methods.  
 





4.4.1 General Information 
All the starting materials were obtained from commercial sources and used 
without further purification unless otherwise stated. THF was dried and distilled 
from sodium benzophenone ketyl prior to use. CH2Cl2 were distilled from CaH2 
prior to use. 1H and 13C NMR spectra were recorded on a Bruker AMX500 (500 
MHz) spectrometer. Chemical shifts were reported in parts per million (ppm), and 
the residual solvent peak was used as an internal reference: proton (chloroform δ 
7.26), carbon (chloroform δ 77.0). Multiplicity was indicated as follows: s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), and br s 
(broad singlet). Coupling constants were reported in Hertz (Hz). Low resolution 
mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI mode, and 
a Agilent Tech. 5975C inert MSD. All high resolution mass spectra were obtained on 
a Finnigan/MAT 95XL-T spectrometer. For thin layer chromatography (TLC), 
Merck pre-coated TLC plates (Merck 60 F254) were used, and compounds were 
visualized with a UV light at 254 nm. Further visualization was achieved by staining 
with iodine, or ceric ammonium molybdate followed by heating on a hot plate. Flash 
chromatographic separations were performed on Merck 60 (0.040-0.063 mm) mesh 
silica gel. The Enantiomerically excesses of products were determined by 
chiral-phase HPLC analysis, using a Daicel Chiralpak IA column (250 x 4.6 mm), 
Chiralpak AD-H column (250 x 4.6 mm), or Chiralcel IC column (250 x 4.6 mm). 
 
4.4.2 General procedure for preparation of ligands  
 





To a solution of aminophosphine 4-52 (0.22 mmol) and Et3N (62 L, 0.44 mmol) 
in anhydrous CH2Cl2 (1.0 mL) was slowly added a solution of 
3,5-bis(trifluoromethyl)benzoyl chloride (49 L, 0.27 mmol) at 0 oC. The resulting 
mixture was stirred at the same temperature for 1h. Water (2 mL) was added and the 
organic layer was separated. The aqueous phase was extracted with CH2Cl2 (2x3 mL). 
The combined organic layers was washed with brine and dried over Na2SO4. Solvent 
was removed under vacuum and the residue was purified column chromatography on 
silica gel using hexane/ethyl acetate as an eluent to afford  4-2 (91 mg, 83% yield) as a 
white solid. 
1H NMR (500 MHz, CDCl3) δ 1.46 (d, J = 7.0 Hz, 6H), 4.49 (d, J = 7.0 Hz, 2H), 
4.44-4.50 (m, 1H), 6.08 (s, 1H), 7.25-7.34 (m, 6H), 7.42 (td, J = 7.6 Hz, 1.3 Hz, 2H), 
7.49 (td, J = 7.6 Hz, 1.3 Hz, 2H), 7.96 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 24.20 
(d, J = 10.0 Hz), 35.81 (d, J = 15.5 Hz), 45.28 (d, J = 15.7 Hz), 121.80, 123.97, 
124.75 (d, J = 4.6 Hz), 127.12, 128.62 (d, J = 3.6 Hz), 128.68 (d, J = 3.6 Hz), 128.95 
(d, J = 10.0 Hz), 131.95 (q, J = 34.6 Hz), 134.64 (d, J = 10.9 Hz), 134.79 (d, J = 14.3 
Hz), 136.55, 137.70 (d, J = 10.9 Hz), 138.06 (d, J = 11.8 Hz), 163.56; 31P NMR (121 
MHz, CDCl3) δ -24.45; HRMS (ESI) m/z calcd for C24H20F6NOP [M+H]+ = 





4.4.2.2 Phosphine-amide ligands from L-threonine 
 
 
To a solution of 4-53 (546 mg, 2 mmol) and Et3N (417 μL, 3 mmol) in anhydrous 
CH2Cl2 (30 mL) was slowly added a solution of 3,5-bis(trifluoromethyl)benzoyl 
chloride (360 μL, 2 mmol) in CH2Cl2 (30 mL) at -50oC over 30 min. The resulting 
mixture was stirred at the same temperature for 1h and then warmed to room 
temperature. Water (45 mL) was added and the organic layer was separated. The 
aqueous phase was extracted with CH2Cl2 (2 x 15 mL). The combined organic layers 
were washed with brine and dried over Na2SO4. Solvent was removed under reduced 
pressure and the residue was purified by column chromatography on silica gel using 
hexane/ethyl acetate to afford 4-54 (630 mg, 62% yield) as a white solid. 
To a solution of 4-54 (61 mg, 0.12 mmol) in dry DMF (28 L, 0.36 mmol) was 
added imidazole (25 mg, 0.36 mmol) and tert-butyldimethylsilyl chloride (22 mg, 0.15 
mmol) at room temperature under N4. The solution was stirred for 36 h, and the mixture 
was directly purified by column chromatography using hexane/ethyl acetate as eluent 
to afford 4-4 as a white solid (61 mg, 81 % yield). 




Hz, 3H), 4.27 (dd, J = 7.6 Hz, 13.3 Hz, 1H), 4.64-4.68 (m, 1H), 4.15-4.18 (m, 1H), 
4.31-4.35 (m, 1H), 6.66 (d, J = 8.9 Hz, 1H), 7.30-7.38 (m, 6H), 7.39-7.41 (m, 2H), 
7.56-7.59 (m, 2H), 7.99 (s, 1H), 8.11 (s, 2H); 13C NMR (125 MHz, CDCl3) δ 17.91, 
21.26, 25.78, 29.65, 31.47 (d, J = 13.7 Hz), 53.40 (d, J = 15.6 Hz), 69.23 (d, J = 10.9 
Hz), 123.99, 124.86, 127.08, 128.57 (d, J = 7.3 Hz), 128.69 (d, J = 7.3 Hz), 128.81, 
129.18, 134.76 (q, J = 28.8 Hz), 136.52, 163.54; 31P NMR (121 MHz, CDCl3) δ -24.77; 
HRMS (ESI) m/z calcd for C31H36F6NO2PSi [M+H]+ = 628.2230, found = 628.2240. 




















4-56 4-9  
To a stirred solution of N-Boc L-valine 4-55 (0.176 g, 0.82 mmol) in anhydrous DCM 
(5 mL) was added DCC (84 mg, 0.41 mmol), and the resulting mixture was stirred at 
room temperature for 2 h. The solution was then cooled to 0 oC and a solution of (0.1 
g, 0.37 mmol) inDCM (1 mL) was added dropwise over 2 minutes. The reaction 
mixture was f stirred for additional 0.5 h at 0 oC and 0.5 h at room temperature. Water 
(10 mL) was added to quench the reaction, and the resulting mixture was extracted 
with DCM (3 x 10 mL). The combined organic extracts were dried over Na2SO4, 
filtered, concentrated, and the residue was purified by column chromatography using 
hexane/EA as eluent to afford 4-56 (0.138 g, 79%) as a white solid. To a solution of 
3-13in anhydrous DCM (5 mL) at 0 oC was added TEA (61 μL, 0.44 mmol), followed 




allowed to warm to room temperature and continued stirring for additional 1 hour. 
The reaction was quenched with saturated aqueous NaHCO3 (10 mL) and extracted 
with DCM (2 × 20 mL). The combined organic extracts were washed with brine, and 
dried over Na2SO4. Purification by column chromatography using hexane/EA as 
eluent to afford 4-9 (0.140 g, 82% yield) as a white solid. 
1H NMR (300 MHz, CDCl3) δ7.59-7.28 (m, 10H), 6.32 (s, 1H), 5.03 (s, 1H), 
4.34-4.26 (m, 1H), 3.95-3.75 (m, 2H), 4.38 (dd, J = 3.9, 10.5 Hz, 1H), 4.20-4.12 (m, 
2H), 1.42 (s, 9H), 1.07 (d, J = 6.0 Hz, 3H), 0.98-0.90 (m, 15H), 0.10 (d, J = 4.1 Hz, 
6H); 13C NMR (75 MHz, CDCl3) δ170.9, 138.6, 134.9, 134.7 (d), 134.5, 128.4 (dd), 
79.6, 68.2(d), 60.0, 54.3 (d), 31.7 (d), 20.8, 19.2, 17.7 (d), -4.5; 31P NMR (121 MHz, 
CDCl3) δ-23.9 (s); HRMS (ESI) m/z calcd for C32H52N2O4PSi [M+H]+ = 587.3428, 
found = 587.3449; [α]25D= -19.7 (c 0.80, CHCl3). 
 
4.4.2.4 Phosphine-thiourea ligands from L-threonine 
 
To a solution of the amino phosphine 4-53 (82 mg, 0.30 mmol) in CH2Cl2 (2 mL) 
was added 4-fluorophenyl isocyanate (46 mg, 0.33 mmol) under N2 and the reaction 
mixture was stirred at room temperature for 2 hrs. Solvent was removed under 
reduced pressure and the residue was directly subjected to column chromatographic 




intermediate (94 mg, 0.23 mmol). This intermediate was then dissolved in anhydrous 
CH2Cl2 (2 mL), followed by the addition of DIPEA (119 L, 0.69 mmol) and  
tert-butyldimethylsilyl trifluoromethanesulfonate (63 L, 0.28 mmol). The reaction 
mixture was stirred at room temperature for 1 h, and solvent was removed. The 
residue was directly purified by column chromatography on silica gel using 
hexane/ethyl acetate as an eluent to afford 4-27 as a white solid (107 mg, 68% yield). 
A white solid; 61% yield;  
1H NMR (500 MHz, CDCl3) δ 0.04 (s, 6H), 0.66 (s, 9H), 1.13 (d, J = 3.6 Hz, 3H), 
4.16 (br, 1H), 4.68 (br, 1H), 4.34-4.40 (m, 2H), 6.46 (br, 1H), 7.30-7.40 (m, 8H), 7.61 
(br, 2H), 7.71 (br, 3H), 8.40 (s, 1H); 13C NMR (125 MHz, CDCl3) δ -4.72, -4.70, -4.35, 
17.69, 21.32, 25.53, 31.57 (d, J = 14.7 Hz), 58.72 (d, J = 16.7 Hz), 68.60 (d, J = 10.2 
Hz), 120.05, 121.61, 123.78, 124.91, 128.48, 128.53, 128.72, 128.99, 134.65, 134.80, 
133.02, 133.17, 137.05, 138.39, 180.30; 31P NMR (121 MHz, CDCl3) δ -24.12; HRMS 
(ESI) m/z calcd for C31H37F6N2OPSSi [M+H]+ = 659.2110, found = 659.2114. 











Ph4-57 4-34  
To a stirred solution of cinnamic acid (0.82 mmol) in anhydrous DCM (5 mL) was 
added EDCI (0.41 mmol), and the resulting mixture was stirred at room temperature 
for 2 h. The solution was then cooled down to 0 oC and a solution of  aminophoshine 
4-57 (0.37 mmol) inDCM (1 mL) was added dropwise over 2 minutes. The reaction 




(10 mL) was added to quench the reaction, and the resulting mixture was extracted 
with DCM (3 x 10 mL). The combined organic extracts were dried over Na2SO4, 
filtered, concentrated, and the residue was purified by column chromatography using 
hexane/EA as eluent to afford 4-34 (0.18 g, 82%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ 7.65–7.55 (m, 3H), 7.50 (dd, J = 7.6, 1.4 Hz, 2H), 7.37 
(qt, J = 7.8, 4.6 Hz, 8H), 7.32 (dd, J = 13.0, 3.3 Hz, 3H), 6.30 (d, J = 15.6 Hz, 1H), 
5.93 (d, J = 7.9 Hz, 1H), 4.30 (q, J = 6.1 Hz, 1H), 4.19–3.95 (m, 1H), 4.61–4.41 (m, 
1H), 4.37–4.18 (m, 1H), 1.12 (d, J = 6.2 Hz, 3H), 0.93 (s, 10H), 0.13 (d, J = 4.3 Hz, 
7H); 13C NMR (126 MHz, CDCl3) δ 165.40, 140.90, 134.90, 133.00, 134.85, 134.81, 
134.66, 129.56, 128.87, 128.74, 128.67, 128.61, 128.49, 128.43, 127.78, 120.77, 
68.92, 68.83, 54.60, 54.48, 31.62, 31.52, 25.94, 25.63, 20.77, 18.04, -4.23, -4.53. 31P   
NMR (202 MHz, CDCl3) δ -23.03. 
 
4.4.2.6 Phosphine-imine ligands 
 
To a solution of the amino phosphine 4-57 (82 mg, 0.30 mmol) in toluene (2 mL) was 
added benzyl aldehyde (30 L, 0.3 mmol) under N2 and the reaction mixture was 
stirred at room temperature for 6 h. Solvent was removed under reduced pressure and 
the residue was used without purification.  
1H NMR (500 MHz, CDCl3) δ 8.05 (s, 1H), 7.62 (d, J = 6.3 Hz, 2H), 7.52 – 7.44 (m, 




4.51 (d, J = 6.6 Hz, 2H), 4.01 (dq, J = 13.1, 6.6 Hz, 1H), 0.94 (t, J = 7.2 Hz, 6H).; 31P 
NMR (202 MHz, CDCl3) δ -19.98. 
 
 
To a solution of the Pd(MeCN)2Cl2 (51 mg, 0.20 mmol) in benzene (2 mL) was added 
a solution of the phosphine-imine ligand 4-39 (80 mg, 0.22 mmol) under N2 and the 
reaction mixture was stirred at room temperature for 3 h. The precipitate was 
collected by filtration to afford Pd complex 4-40 in 82% yield as a yellow solid. 
1H NMR (300 MHz, CDCl3) δ 8.58 (s, 1H), 8.51 (d, J = 7.4 Hz, 2H), 8.11 – 7.95 (m, 
2H), 7.88 (dd, J = 14.4, 7.1 Hz, 2H), 7.64 – 7.31 (m, 12H), 3.67 (d, J = 41.8 Hz, 1H), 
3.00 (s, 1H), 4.72 (d, J = 11.5 Hz, 2H), 1.17 (d, J = 6.2 Hz, 3H), 0.81 (d, J = 6.3 Hz, 
3H).; 31P NMR (121 MHz, Acetone) δ 40.44. 
 
4.4.3 General procedures for transition-metal-catalyzed reactions 
 
4.4.3.1Pd-catalyzed AAA reaction 
 
To a catalyst solution of palladium catalyst (0.005 mmol) and phosphine ligand (0.01 




mmol) and dimethyl malonate 4-13 (0.15 mol) subsequently under Ar. The resulting 
mixture was allowed to stir at room temperature for 24 h and the mixture was directly 
subjected to column chromatographic separation on silica gel using hexane/ethyl 
acetate as an eluent to afford allylic product 4-15. The ee value of 4-15 was 
determined by HPLC analysis under the condition (Chiralpak IA, λ = 254 nm, 
hexane/i-PrOH = 95/5, flow rate = 1.0 mL/min). 
 
4.4.3.2 Ag-catalyzed Mannich reaction 
 
 
To a catalyst solution of silver catalyst (0.005 mmol) and phosphine-amide ligand 
(0.006 mmol) in THF (0.1 mL) were added glycine imine derivative 4-29 (0.1 mmol) 
and tosyl imine 4-30 (0.12 mol) subsequently under N2. The resulting mixture was 
allowed to stir at room temperature for 12 h and the mixture was directly subjected to 
column chromatographic separation on silica gel using hexane/ethyl acetate as an 
eluent to afford Mannich product 4-31. The d.r. was determined by 1H NMR analysis. 
The ee value of 4-31 was determined by HPLC analysis under the condition 







To a catalyst solution of [Rh(coe)Cl]2 (0.005 mmol) and phosphine-olefin ligand 
(0.012mmol) in dioxane (0.5 mL) were added cyclohexenone 4-37 (0.1 mmol), b 
benzeneboronic acid and potassium hydroxide aqueous solution (0.05 mmol) 
subsequently under N2. The resulting mixture was allowed to stir at room temperature 
for 12 h and the mixture was directly subjected to column chromatographic separation 
on silica gel using hexane/ethyl acetate as an eluent to afford adduct product 4-38.  
 
4.4.4.4 Pd catalyzed 1,2-addition 
 
Palldium complex (0.0050 mmol), ketamine 4-48 (0.100 mmol), and benzeneboronic 
acid  (24.4 mg, 0.200 mmol) were placed in Schlenk tube under nitrogen. To the tube, 
1,2-dichloroethane (0.5 mL) was added, and then AgBF4 (0.015 mmol) in 
1,2-dichloroethane (0.5 mL) was added. The reaction mixture was stirred at 65–70 °C 
for 12 h, and the mixture was directly subjected to flash chromatography on silica gel 
using hexane/ethyl acetate (4:1) as an eluent to give 4-49 as a colorless solid. The ee 
value of 4-49 was determined by HPLC analysis under the condition (Chiralpak IC, λ 
= 220 nm, hexane/i-PrOH = 9/1, flow rate = 1.0 mL/min). 
